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ABSTRACT 
Pediatric patients are at an increased risk for medication errors and can benefit from processes 
that facilitate and promote medication safety (Stone et al., 2010). Medication reconciliation (Med 
Rec) is a valuable tool in improving patients’ medication safety and reducing adverse drug 
events (The Joint Commission, 2015). The purpose of this evidence-based practice (EBP) 
project was to improve the accuracy of the Med Rec process in a Midwestern pediatric 
hematology/oncology outpatient clinic by developing, promoting, and evaluating a standardized, 
collaborative Med Rec process. The Stetler EBP model guided the implementation of the 
intervention, with the goal of integrating current evidence into current practice. Kotter’s Model of 
Change laid the theoretical foundation for successful implementation of a current practice 
change. This EBP project intervention included a patient and team member component. The 
patient component consisted of a verbal call reminder to bring medications to the visit, a patient 
handout emphasizing the importance of medication safety and reconciliation, and patient 
education regarding Med Rec process. The team member component included education 
regarding the importance of the Med Rec process and updates regarding Med Rec accuracy. 
The outcomes measured included the number, type, and severity of medication discrepancies 
and the number of voluntarily reported medication errors. Data were collected during Phase 1 
(pre-intervention) and Phase 2 (post-intervention) by the physicians and the project leader (PL). 
These data were analyzed using chi-square tests. The intervention lead to a significant increase 
in the number of accurate Med Recs reported by the physicians between Phase 1 (n = 50, 70%) 
and Phase 2 (n = 65, 90.8%) (X2 = 8.167, df = 1, p = .004). An insignificant decrease in the 
number of accurate Med Recs was reported by the PL between Phase 1 (73.1%) and 2 (72.5%) 
(X2 = .003, df = 1, p = 0.959). Physicians reported more incorrectness errors in Phase 1 (73.3%) 
and Phase 2 (83.3%) than incompleteness errors (X2 = .481, df = 1, p = .786). PL reported more 
incompleteness errors in Phase 1 (71.4%) and Phase 2 than incorrectness errors (81.8%) (X2 = 
1.670, df = 2, p = .434). The majority of Med Rec inaccuracies were classified as minor during 
 x 
Phase 1 and 2 by the physicians (X2 = .827, df = 2, p = .363) and the PL (X2 = 1.039, df = 1, p = 
.308). No inaccurate Med Rec was classified as severe by physicians or the PL. Finally, there 
were no voluntary medication errors were reported during the duration of the EBP project. 
Revision and replication of this EBP project would be helpful in further improving Med Rec 
accuracy in this setting. 
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CHAPTER 1 
INTRODUCTION 
In recent years, the importance of medication safety has been emphasized by 
healthcare regulatory bodies. Medication safety has also been the focus of several 
internationally lead initiatives (Agency of Healthcare Research and Quality (AHRQ), 2012; 
Institute of Healthcare Improvement (IHI), 2016; The Joint Commission, 2015; World Health 
Organization (WHO), 2015). In 2006, in an effort to improve medication safety, the Joint 
Commission called for accurate and complete medication reconciliation (Med Rec) across the 
continuum of care (Varkey, Cunningham, & Bispring, 2007).  
The Joint Commission’s third National Patient Safety Goal (NPSG), in 2015, was to 
improve the safety of using medications (The Joint Commission, 2015). This goal emphasized 
an organization’s focus on the reduction of medication discrepancies and errors (The Joint 
Commission, 2015). Specifically, NPSG.03.06.01 cites the role of Med Rec in improving 
medication safety (The Joint Commission, 2015). According to the Joint Commission (2015), 
Med Rec facilitates identifying and resolving medication discrepancies, such as duplications, 
omissions, and interactions (The Joint Commission, 2015). 
According to the IHI (2016), Med Rec can be defined as “a process of identifying the 
most accurate list of all medications a patient is taking — including name, dosage, frequency, 
and route — and using this list to provide correct medications for patients anywhere within the 
health care system (Medication Reconciliation Review section, para. 2).” Med Rec plays a 
pivotal role in identification and correction of medication discrepancies, leading to improved 
medication safety (The Joint Commission, 2015). The ultimate goal of Med Rec is to create an 
all-inclusive medication list that informs both the patient and the healthcare provider (The Joint 
Commission, 2015). Med Rec is the responsibility of the patient and the entire healthcare team 
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(Redmond et al., 2013). Developing and agreeing on an accurate medication list is a 
collaborative effort. 
The Med Rec process has three steps: verification, clarification, and reconciliation 
(Redmond et al., 2013). Verification is the act of generating a list of the patient’s current 
medications, using various sources of information (Redmond et al., 2013). The sources of 
information can include: the patient, the general practitioner, the electronic health record (EHR), 
or the pharmacy records (Redmond et al., 2013). Medications include prescription medications, 
over-the-counter (OTC) medications, vaccines, vitamins, nutritional supplements, and 
complementary medications (AHRQ, 2015; Barnsteiner, 2008). After the medication list is 
verified, clarification occurs. Clarification occurs when the medications are checked for 
appropriateness (Redmond et al., 2013). In this instance, appropriateness means intentional or 
unintentional changes to the medication list that need to be made (Redmond et al., 2013). The 
final step in the process is when the medication list is reviewed and any changes are 
documented (Redmond et al., 2013). Changes can include medication additions, subtractions, 
or modifications (Redmond et al., 2013). Failure to ensure an accurate medication list may 
result in medication error, subsequent adverse drug events (ADEs), and ultimately comprised 
patient safety (Redmond et al., 2013). 
Med Rec should be performed at any and all transitions of care (AHRQ, 2012; IHI, 2016; 
The Joint Commission, 2015). Transitional care can be defined as “changes in the level, 
location, or providers of care as patients move within the healthcare system (Redmond et al., 
2013, p. 3).” Transitions of care can include: admission, discharge, and transfer (AHRQ, 2012). 
Transitions of care are particularly vulnerable times, in which medication discrepancies and 
errors occur more frequently (AHRQ, 2012). According to Redmond et al. (2013), more than 
40% of medication errors take place at transitions of care as a result of inaccurate Med Rec. In 
addition, it was found that there was a 30-70% variance in medications prior to and after 
hospital admission, a transition of care (AHRQ, 2012).    
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Med Rec is not without its challenges. Challenges include: accuracy of patient 
information given to the healthcare provider, willingness of the patient to give information, time 
efficiency, and effectiveness of the electronic or paper documenting system (The Joint 
Commission, 2015). Coffey, Cornish, Koonthanam, Etchells, and Matlow (2009) cited barriers to 
Med Rec that included: a multi-step process, the inter-professional nature of the Med Rec, 
staffing resources, and frequent staff turnover. Despite these barriers healthcare providers are 
urged to make a good faith effort to complete an accurate and complete Med Rec, at all 
transitions of care (The Joint Commission, 2015). 
The use of Med Rec has been shown to decrease medication errors and subsequent 
ADEs (IHI, 2016; Redmond et al., 2013). Med Rec has been studied in many clinical practice 
settings, such as inpatient hospitals and outpatient offices. For example, Varkey et al. (2007) 
examined improving the Med Rec process, in an adult outpatient primary care setting. The 
authors found that after a multifaceted intervention the average number of medication 
discrepancies per patient decreased by more than 50%, from 5.24 to 2.46 discrepancies per 
patient (Varkey et al., 2007).  
In addition to various settings, Med Rec has been examined and shown to be 
promisingly beneficial in different age groups (Coffey et al., 2009; Gardner & Graner, 2009; 
Huynh et al., 2016; Nassaralla, Naessens, Chaudhry, Hansen, & Scheitel, 2007; Stone, 
Boehme, Mundorff, Maloney, & Srivastava, 2010; Terry, Solanki, Sinclair, Marriott, & Wilson, 
2010; Varkey et al., 2007, Weingart et al., 2007). One study focused on Med Rec process 
implementation at one adult hospital and one pediatric hospital (Coffey et al., 2009). 
Unfortunately, the authors did not provide the pediatric specific data, regarding the reduction in 
medication discrepancies. However, at the adult hospital, implementation of a Med Rec process 
decreased the total number of discrepancies identified from 224 to 120 (Coffey et al., 2009).   
 As discussed previously, both adult and pediatric studies have examined the effect of 
implementing a Med Rec process. Med Rec can be an extremely important tool in pediatric 
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patient care. Pediatric medication safety is oftentimes complex for many reasons, including: 
weight based calculations, various medication formulations, and developmental levels making it 
difficult for children to communicate adverse reactions (Stone et al., 2010). Healthcare providers 
must have an accurate weight, convert the weight to kilograms, and then chose the appropriate 
medication formulation and concentration (McPhillips et al., 2005). These steps make children 
particularly vulnerable to medication errors. After the medication is prescribed, the caregivers of 
the child must be educated to ensure proper medication administration at home.  
When Kaushal et al. (2007) examined the rates and types of ADEs in six pediatric 
outpatient offices, they found that the rate of preventable ADEs was 3% in two months (95% CI 
[3, 4]) and that 14% of the preventable ADEs were serious. Kaushal et al. (2007) also found that 
47% of the preventable ADEs were related to parent drug administration. The authors 
recommended improved communication regarding medications between healthcare providers 
and parents to reduce ADEs (Kaushal et al., 2007). Furthermore, Walsh et al. (2009) examined 
medication errors among adults and children with cancer in an outpatient setting. Almost 19% of 
pediatric visits involving medications were associated with a medication error (95% CI [12.5, 
26.9]) (Walsh et al., 2009). This rate was higher than the adult comparison group with only 7.1% 
of visits associated with a medication error (Walsh et al., 2009).  
Cancer care has recently shifted from mostly inpatient care to the majority of care 
occurring in the outpatient setting. This shift relocates the complex care oncology patients 
receive to outpatient settings. According to Walsh et al. (2009), “systems to prevent outpatient 
medication errors are often inadequate because of factors such as lack of recognition of errors, 
communication problems, and fragmentations of care (p. 891).” Oncology patients receive 
complex chemotherapy regimens in an outpatient setting. In addition, oftentimes part of their 
chemotherapy regimen is oral chemotherapy administered at home (Walsh et al., 2009). The 
complexity of oncology care, coupled with the complexity of pediatric medication administration 
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places pediatric oncology patients at a significant risk for medication discrepancies and 
subsequent ADEs (Walsh et al., 2009).  
 The purpose of this evidence-based practice (EBP) project was to improve the accuracy 
of the Med Rec process in a pediatric hematology/oncology outpatient clinic by developing, 
promoting, and evaluating a standardized, collaborative Med Rec process.   
Background 
As previously mentioned, the Joint Commission’s third 2015 NPSG focused on 
medication safety. Accredited organizations are required to complete Med Rec at transitions of 
care (The Joint Commission, 2015). In addition to the Joint Commission, the IHI also 
emphasized the importance of medication safety, more specifically the role of Med Rec in 
medication safety (IHI, 2016). In 2005, the IHI launched its 100,000 Lives Campaign with the 
goal of reducing morbidity and mortality in the United States (IHI, 2005). One of the pillars of the 
100,000 Lives Campaign was implementing Med Rec, specifically with the goal of preventing 
ADEs (IHI, 2005). 
 In addition to the Joint Commission and the IHI, the World Health Organization (WHO) 
formulated the High 5s Project in 2006. The goal of the High 5s Project was to improve patient 
safety by implementing standardized operating protocols (SOPs) (WHO, 2013). One of the High 
5s SOPs focused on Med Rec at transitions of care (WHO, 2013). The WHO (2015) stated that 
“each SOP summarizes the problem, the strength of evidence that supports the solution, 
potential barriers to adoption, potential unintended consequences created by the solution, 
patient and family roles in the solution, and references and resources (Standard Operating 
Protocols section, para. 2).” 
 Finally, the AHRQ and the National Institute for Health and Care Excellence (NICE) 
developed and updated a guideline in 2015 entitled “Medicines Optimization: The Safe and 
Effective Use of Medicines to Enable the Best Possible Outcomes (AHRQ, 2015).” The goal of 
this guideline was to explain the best practice of care for patients who require medications. The 
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guideline specifically discussed Med Rec at transitions of care. Particularly of relevance to this 
project, the guideline recommends Med Rec in primary care settings be completed when a 
patient is discharged from the hospital or another care setting and before any new prescription 
or medication changes are made (AHRQ, 2015). The AHRQ is also responsible for the 
development of a toolkit entitled “Medications at Transitions and Clinical Handoffs (MATCH) 
Toolkit for Medication Reconciliation (AHRQ, 2012).” The toolkit urges healthcare providers to 
review and re-design the Med Rec process currently in place at their clinical sites, in order to 
improve patient safety (AHRQ, 2012). The toolkit has seven chapters that detail the process of 
re-designing an existing Med Rec process (AHRQ, 2012). 
Despite the AHRQ, the IHI, the Joint Commission, and the WHO recommending the use 
of Med Rec, there is currently no specific recommendations from these organizations for Med 
Rec in the pediatric outpatient setting. Team members at such facilities can certainly use these 
organizations recommendations to develop a standardized, collaborative Med Rec process that 
ensures accurate Med Rec and medication safety. Research examining Med Rec in outpatient 
or ambulatory care settings is invaluable, as well as research examining Med Rec in pediatrics.   
Statement of the Problem 
This EBP project addressed the medication discrepancies found in completed Med 
Recs, specifically the Med Recs in a pediatric hematology/oncology outpatient clinic. The impact 
of a standardized, collaborative Med Rec process was examined. The pediatric and oncological 
aspects of the population made the population extremely vulnerable to medication errors and 
subsequent ADEs. 
Data from the Literature Supporting Need for the Project 
Extensive research has been conducted verifying the role of Med Rec in the reduction of 
medication errors; however, little literature exists examining the impact of Med Rec in the 
pediatric outpatient population. In a study using Med Rec in one pediatric and two adult 
outpatient oncology clinics, 90% of incorrect medications lists were updated when a Med Rec 
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process was used (Weingart et al., 2007). This result was in contrast to the standard care 
group, where only 2% of medication lists were corrected (p < .001) (Weingart et al., 2007). 
Standard care involved no formal reconciliation process. In the standard care group, 0.1 
medication changes per patient were made, compared to 4.3 medication changes made in the 
Med Rec group (p < .001) (Weingart et al., 2007). The rate of medication changes indicated the 
medication list was being updated and revised. The Med Rec process included input from the 
patient, nurse, healthcare provider, and the pharmacist, emphasizing the importance of a 
collaborative effort to improve medication safety (Weingart et al., 2007). 
A review of literature by Huynh et al. (2013) concluded that there was a lack of strong, 
consistent evidence showing improvement of pediatric patient safety using Med Rec. However, 
it was obvious that medication discrepancies were a major problem at transitions of care. Four 
of the ten studies reviewed reported 22 to 73.6% of patients had an unintended medication 
discrepancy or medication error. One study, included in the review, reported a rate of 1.5 
discrepancies per patient. All ten of the studies included some form of a Med Rec intervention 
(Huynh et al., 2013). The results of this review may indicate that Med Rec at pediatric transitions 
of care is not as effective as what has been shown in adults. Further research is needed. 
 Most studies examining Med Rec in the pediatric population have been conducted in the 
inpatient setting. A study, conducted in a tertiary care children’s hospital, examined the effect of 
an EHR tool that displayed a patient’s pre-admission medication list beside the admission 
medication orders (Hron et al., 2015). The use of this EHR tool lead to a statistically significant 
decrease (53%) in rate of Med Rec errors (MREs) post intervention (p = .02; 95% CI [26, 87]). 
Also, the risk of reported ADEs related to admission Med Rec was significantly lower post-
intervention (R2 = .24; p < .001; 95% CI [0.11, 0.53]) (Hron et al., 2015).  
 Huynh et al. (2016) conducted a study in which a clinical pharmacist provided several 
points of care (a) interviewed the caregiver, (b) called the primary care provider (PCP) to obtain 
the medication record, (c) recorded the patients medications brought from home, and (d) 
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examined the initial admission medication orders. This intervention lead to the identification of 
582 medication discrepancies in 1004 prescriptions (58%). Of those 582 medication 
discrepancies, 209 were unintentional, 277 were intentional, and 96 were determined to be 
trivial or related to nutrition. The authors concluded that Med Rec decreased the risk of harm 
from unintended medication discrepancies. Also, with specific relevance to pediatric patients, 
parents or caregivers were identified as the most sensitive or accurate source of information 
(Huynh et al., 2016). 
 With little evidence in the literature focused on pediatric outpatient Med Rec, adult 
outpatient studies shed light on the improvement of the outpatient Med Rec process. In an adult 
internal medicine outpatient clinic, individual medication completeness improved from 9.7% to 
70.7% (p < .001) after implementing an intervention that standardized the entire patient visit 
process (Nassaralla et al., 2007). The entire medication list completeness improved from 7.7% 
to 18.5%. The standardized visit process included (a) the patients being reminded to bring an 
updated list of medications or the medication containers to their appointment; (b) the patients 
recording the medications on a form when they arrived to their appointment; (c) a licensed 
practical nurse (LPN) recording the medications in the EHR; (d) the physician continuing, 
adding, deleting, or modifying the medications in the EHR; and (e) the transcriptionist checking 
for differences between the physicians dictation and the patients documented medication list in 
the EHR (Nassaralla et al., 2007). 
 In a similar study conducted at four adult ambulatory, primary care, internal medicine 
clinics, the effect of a three phase intervention on Med Rec accuracy was assessed. The three 
phases included (a) baseline data collection, (b) a LPN intervention, and (c) a patient 
awareness intervention. After the interventions, a statistically significant increase in the number 
of complete medications (76.5% to 88.3%) and complete medication lists (20.4% to 50.4%) 
occurred (p < .03). Also, accuracy significantly improved from the pre-intervention phase to the 
patient intervention phase from 11.5% to 29% (p = .014) (Nassaralla et al., 2009). 
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In the literature, there currently is very little data focused on the pediatric outpatient 
population and the Med Rec process. There are data from pediatric inpatient population studies 
that support the use of accurate Med Rec’s. These data from the pediatric inpatient studies 
emphasize the uniqueness of the pediatric population and emphasize the importance of 
improving medication safety. As previously discussed, pediatric patients are at an increased risk 
for medication errors given the steps involved in prescribing and administering medications 
(McPhillips et al., 2005; Stone et al., 2010). When examining the applicability of the pediatric 
inpatient Med Rec studies to the pediatric outpatient setting problems arise. The pediatric 
inpatient setting Med Rec process, interventions, and outcomes differ from the Med Rec 
process in the pediatric outpatient setting. For example, the outcome of many pediatric inpatient 
Med Rec studies is often based on a comparison between the patient’s home medication list 
and the admission medication orders. In the outpatient setting, there are no admission 
medication orders that can be compared to the patient’s home medication list to determine Med 
Rec accuracy. On the contrary in the outpatient setting, there is one list of the patient’s home 
medications that is reviewed and updated. Although the adult outpatient studies focus on a 
different population, the setting in which they take place has similar processes, interventions, 
and measureable outcomes when compared to a pediatric outpatient setting. Given the lack of 
existing pediatric outpatient data, the adult outpatient studies can serve as a framework for 
improving the Med Rec process in a pediatric outpatient setting. It is imperative that the unique 
aspects and needs of the pediatric population not be disregarded when examining the adult 
outpatient studies for ways in which to improve patient medication safety. 
Data from the Clinical Agency Supporting Need for the Project 
In a pediatric hematology/oncology outpatient clinic, the project leader (PL) observed a 
large number of medication discrepancies occurring at all three stages of the Med Rec process: 
verification, clarification, and reconciliation. The clinic director and pediatric 
hematology/oncology physicians were approached and also cited frustrations with the accuracy 
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and effectiveness of the Med Rec process. As stated by one physician, “there is room for 
improvement in our medication reconciliation process.” The director also evidenced a need for 
improvement in an email communication stating “I know we continue to struggle with that 
[medication reconciliation].” 
Prior to this project, the Med Rec process at the agency had no accuracy assessment in 
place. When asked about the frequency of medication discrepancies one physician stated “I find 
errors every day.” The topic of Med Rec was discussed in depth with the clinic director and 
various team members. All were receptive to making an EBP change in an attempt to improve 
the Med Rec process and ultimately medication safety. 
Purpose of the Evidence-Based Practice Project 
Compelling Clinical Question 
The purpose of this EBP project was to reduce the number of medication discrepancies 
using a standardized, collaborative Med Rec process. The clinical question this EBP project 
addressed was: Will a standardized, collaborative Med Rec process that is communicated to all 
team members and patients, decrease the number of medication discrepancies? 
PICOT Question 
A PICOT question was developed and was related to the clinical question. The question 
included the patient population (P), intervention of interest (I), comparison of interest (C) 
outcome of interest (O), and the time (T). The PICOT question was as follows: In the pediatric 
hematology/oncology outpatient population, how will the implementation of a standardized, 
collaborative Med Rec process affect the number of medication discrepancies over the course 
of two months, when compared to the current Med Rec practice? 
Significance of the EBP Project 
The goal of this EBP project was to reduce the number of medication discrepancies and 
improve the current Med Rec process. The measureable outcome was the number of 
medication discrepancies found prior to and after the intervention implementation. The severity 
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and type of medication discrepancies were also recorded, in an effort to predict the potential 
outcome of the discrepancy. The project site had a Med Rec process in place prior to this EBP 
project, which fulfills the Joint Commission’s NPSG.03.06.01, that a Med Rec process must be 
in place to be accredited (The Joint Commission, 2015). However, according to the PL’s 
observation and various sources in the pediatric hematology/oncology outpatient clinic the Med 
Rec process was not accurate. Ultimately, the accuracy of the Med Rec affects the patient’s 
medication understanding and home medication administration.  
The final goal of this EBP project was to decrease the number of ADEs reported in the 
project sites computer system, related to medication errors. At the time of the EBP project, team 
members were reminded to report ADEs in the electronic incident reporting system. With the 
implementation of a standardized Med Rec process, it was hoped and predicted that there 
would be a consistent or decrease in the number of ADEs reported in the incident reporting 
system. 
It was of utmost importance to keep the patient at the center of the care provided and 
ultimately improve their medication safety. It was important to enlist and motivate all the team 
members at the project site to ensure a collaborative effort. The ultimate goal was to produce 
significant results that would lead to a permanent policy change, within the pediatric 
hematology/oncology outpatient clinic.  
 
 
 
 
  
MEDICATION RECONCILIATION  12  
 
CHAPTER 2 
THEORETICAL FRAMEWORK, EBP MODEL, AND REVIEW OF LITERATURE 
The goal of this EBP project was to use current evidence found in the literature to 
change and improve a clinical problem. It is important to discuss the theoretical framework that 
guided the EBP change in the clinical setting and the EBP model used to guide the 
implementation of this project. The theoretical framework that was used to guide this EBP 
project was Kotter’s Model of Change. In addition to Kotter’s Model of Change, the Stetler EBP 
Model was used to guide the implementation of best practice in the clinical setting. 
Theoretical Framework 
Overview of Theoretical Framework 
The theoretical framework for this EBP project was Kotter’s Model of Change. Kotter’s 
Model of Change laid a foundation to successfully implement an EBP project and change 
current practice. Kotter used Lewin’s Stages of Change as a building block in developing his 
change model (Ritter, 2011). The eight stages of Kotter’s change model are: (1) establish a 
sense of urgency, (2) create a powerful guiding coalition, (3) develop a vision, (4) communicate 
the vision, (5) empower others to act on the vision, (6) plan for and create short-term wins, (7) 
consolidate improvements and produce more change, and (8) institutionalize new approaches 
(Ritter, 2011). Kotter’s first four steps look at changing the current practice or status quo, similar 
to Lewin’s unfreezing stage. Steps five through seven introduce the change, similar to Lewin’s 
change stage. Finally, step eight seeks to make the changes standard practice, similar to 
Lewin’s refreezing stage (Ritter, 2011).  
The goal of the first stage of the Kotter Model of Change is to establish a sense of 
urgency. The sense of urgency is focused on changing a current clinical problem. One strategy 
to establishing urgency is to collect data on the problem that can be used as a tool to 
communicate the scope of the problem (Young, 2015). Establishing a sense of urgency can 
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reduce resistance to change and energize team members to be active participants in the 
change (Fehr, 2016). 
The second stage of Kotter’s Model is to create a powerful guiding coalition. The guiding 
coalition is made up of key stakeholders that can help plan and implement the change (Fehr, 
2016). It is important that this coalition have similar thoughts and ideas, regarding the future of 
the change. A direct result of forming a coalition is collaboration and cooperation (Young, 2015). 
After a coalition is formed, it is important to develop a vision, Kotter’s third stage. The 
coalition works together to formulate a vision and strategy to implement the change (Young, 
2015). The ultimate goal of this step is the development of a vision and strategy that is clearly 
articulated (Fehr, 2016). 
The fourth stage of Kotter’s Model is communicating the vision. According to Fehr 
(2016), in this stage the vision must be communicated clearly, many times, and in different 
forms. Ensuring clear communication can reduce confusion, misunderstandings, and ultimately 
resistance to change (Young, 2015). 
The fifth stage of Kotter’s Model is empowering others to act on the vision. The first four 
steps alone do not cause change to occur. The fifth stage, however, is when the change begins 
to be enacted. For this stage to be successful, all team members feeling and believing in the 
proposed change is essential. The belief in the change will foster a sense of responsibility and 
accountability for the success or failure of the new practice (Young, 2015). This step also 
involves removing barriers to the change, including systems or structures that may impede the 
change process (Ritter, 2011). 
Once team members are empowered, the likelihood the change will be a success 
increases. In order to facilitate continued investment in the change, the sixth stage focuses on 
planning for and creating short-term wins. When a team member models or embraces the 
change, a “short-term win” is created (Young, 2015, p. 456). During this stage, team members 
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are recognized for embracing and accepting the change. This recognition can further team 
member’s investment in the change (Young, 2015).  
Once the change has begun to be accepted and celebrated, it is important to consolidate 
improvements and produce more change, which is the seventh stage in Kotter’s Model. At this 
time, reevaluation of goal and strategies occurs (Fehr, 2016). It is imperative to make certain 
that the change is achieving the desired results. Each team member that accepts and adheres 
to the change is important. The advancement to the eighth, and final stage, is quickened if more 
team members buy into the new practice (Young, 2015). 
The eighth, and final stage, of Kotter’s Model is institutionalizing new approaches. The 
combined effort of all empowered team members can facilitate an anchoring of the change into 
accepted and current practice (Young, 2015). As the change is seen as a success and benefits 
are shown, the process will hopefully no longer be seen as new and difficult. The change will 
become current best practice. 
There are many aspects of change that were considered when implementing this EBP 
project. Improving the Med Rec process, in the pediatric outpatient hematology/oncology 
outpatient clinic, was not without its challenges. These challenges can be considered individual 
or organizational level challenges. Individual barriers can include: fear of the unknown, 
reduction in the need for personal fulfillment, real or perceived stress, loss of status or personal 
power, and loss of equilibrium (Ritter, 2011, p. 375). Organizational barriers can include: lack of 
a change agent, inadequate financial and/or capacity, poor leadership and resistance to change 
by senior management, lack of the necessary technology, time restraints, or poor market 
conditions (Ritter, 2011, p. 375). Kotter’s Model of Change facilitated the triumph over numerous 
barriers, such as the ones listed above.   
Application of Theoretical Framework to EBP Project 
Stage 1-- Establish a sense of urgency. Prior to implementing the change, baseline 
data were collected. These data were used as a tool to communicate and exhibit the clinical 
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problem to team members. The PL collecting and presenting the data to the team members 
produced a sense of urgency. Urgency regarding changing the current practice needed to be 
formulated, in order to ensure decreased resistance and increased buy into the new practice.  
Stage 2-- Create a powerful guiding coalition. By communicating and developing the 
sense of urgency, a coalition was formed. The coalition was a multidisciplinary team of 
individuals, who shared a common goal and vision. The multidisciplinary team included: unit 
assistants, medical assistants (MAs), registered nurses, and physicians.  
Stage 3-- Develop a vision. The coalition, at the project site, developed and strategized 
ways to implement the evidence into practice. The goal and vision of the proposed change was 
an improvement in the Med Rec process. It was the hope of the coalition that the change would 
lead to improved patient safety. Through collaboration and cooperation, a vision of improved 
patient care was realized. 
Stage 4-- Communicate the vision. Communicating the vision clearly was of utmost 
importance. Resistance may have occurred, if the vision was unclear or confusing to team 
members. Communicating the vision of this EBP project occurred in different forms, such as 
verbally, visually via PowerPoint®, and via email.  
Stage 5-- Empower others to act on the vision. The goal of this EBP project was to 
create a sustainable process that continued long after the implementation phase. With this goal 
in mind, it was extremely important to empower the team members, at the project site to believe 
in and act on the vision. This stage was undoubtedly the most challenging stage of the project 
change. Barriers to change were recognized and an attempt was made to overcome them by 
strategically examining the clinical problem. By presenting the baseline data and current 
literature, team members felt a sense of investment in changing the current process. This sense 
of investment lead to the team members working together to improve current practice. 
Stage 6-- Plan for and create short-term wins. As discussed in Young (2015), 
recognizing and rewarding change agents at the clinical site was helpful in facilitating continued 
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support of the proposed change. Encouragement was provided both in person and via email. 
Team members were kept up to date throughout the project. This was beneficial and 
encouraged those resistant to change to actively participate in the change. 
Stage 7-- Consolidate improvements and produce more change. As the project 
proceeded and a few team members took an active role, the change began to not feel so new 
and uncomfortable. On the contrary, the change briefly became part of the standard of care. To 
facilitate team members taking an active role the PL was available to remind and encourage 
team members. Also, the PL advocated for the team members and patients during the project.  
Stage 8-- Institutionalize new approaches. As mentioned previously, one goal of this 
EBP project was to develop a process that is beneficial, to both team members and patients, 
and is sustainable. The sustainability continues to be derived from the empowered team 
members, who invested in the change process.   
Strengths and Limitations of Theoretical Framework for EBP Project 
Kotter’s Change Model was useful when implementing an organizational change. 
Kotter’s Model was easy to follow and simplistic, yet it was also thorough, when it came to the 
entirety of the change process. The additional detail and steps that Kotter’s Model offered, in 
comparison to Lewin’s Model of Change, was helpful to the novice PL. Also, the thoroughness 
was appreciated in a climate, such as the project site, where change was resisted and difficult to 
implement. 
 Kotter’s Change Model contains eight stages, which could be viewed as laborious and 
overwhelming to those implementing a process change. The model was described in a linear, 
step-by-step approach, and this was possibly more simplistic than making changes in a real 
environment. Changing a policy, practice, or process was complex and was affected by many 
circumstances. Finally, Kotter’s Model of Change could be considered a top-down approach. A 
top-down approach, in some environments, may not be the most effective at changing a 
process (Young, 2015).  
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Evidence-based Practice Model 
Overview of EBP Model 
The Stetler Model of Evidence Based Practice was used to guide the implementation of 
this EBP project. The Stetler Model was first published in 1976 and has been revised three 
times since then (Dang et al., 2015). The model gives step-by-step, detailed directions for 
incorporating research into practice. The practitioner-oriented model encourages the 
assessment and use of research in the clinical practice setting, with the goal of providing safe 
and effective care (Dang et al., 2015 & Young, 2015).  
The Stetler Model has five phases: (1) preparation, (2) validation, (3) comparative 
evaluation/decision making, (4) translation/application, and (5) evaluation (Dang et al., 2015 & 
Young, 2015). In the first phase, preparation, a problem is identified; the context of the problem 
is reviewed; and searching for evidence occurs. In the validation phase, the body of evidence is 
systematically searched. The second stage also includes choosing and summarizing the 
evidence. If sufficient evidence is found, in the validation phase, the EBP project progresses to 
the third phase, comparative evaluation/decision making. The third phase involves organizing 
and condensing the evidence. At the end of this phase, the data can be classified into three 
categories: (a) do not use, (b) use, or (c) consider for later use. The fourth phase involves the 
actual change in practice, or translation/application. The evidence is converted into the 
recommended intervention of change. The application is planned and the implementation 
strategy is put into action. Evaluation is the fifth, and final stage, of the Stetler Model. The 
evaluation stage involves evaluating the plan and determining if the goals were met (Dang et al., 
2015 & Young, 2015). 
Application of EBP Model to EBP Project 
 Phase 1-- preparation. According to many nationally recognized organizations, such as 
the Joint Commission and the WHO, Med Rec can reduce ADEs (WHO, 2013; The Joint 
Commission, 2015). It is recommended that Med Rec be done thoroughly and accurately to 
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ensure the best possible medication history (BPMH) be formulated. This BPMH should be 
formulated collaboratively, with the patient and the healthcare providers, at each encounter. 
During this phase of the Stetler Model, the current state of the Med Rec process was assessed, 
at the project site. It was found that multiple team members had concerns about (a) the 
accuracy of the medication information provided by the caregiver, (b) the medication history 
entered by the nurse, and (c) the reconciliation process as a whole. The accuracy of the Med 
Rec process was the identified problem. The context of the problem was reviewed to further 
determine the specific areas of the process that need improvement. A multiple database search 
found literature dedicated to the Med Rec process. 
 Phase 2-- validation. After multiple databases were searched and literature was found, 
the literature underwent systematic critiquing to evaluate the literatures strength and relevance. 
Evidence was rated using the Melnyk and Fineout-Overholt (2015) levels of evidence rating 
system. If the evidence was found to be relevant and applicable to the EBP project, it was 
further critiqued using the Johns Hopkins Research or Non-Research Appraisal Tool (Dearholt 
& Dang, 2012).   
 Phase 3--decision making. After the research was narrowed and critiqued to include 
literature relevant to the EBP project, the literature was organized. Common themes were found 
and the evidence was placed into one of three categories. The Stetler Model recommended 
categories were (a) do not use, (b) use, or (c) consider for later use. The current Med Rec 
process was reviewed and a PICOT question was developed. 
 Phase 4-- application. The application phase began after the project intervention was 
developed, based on the relevant evidence. Also, institutional review board (IRB) approval from 
both Valparaiso University and the project site was obtained, to properly protect the projects 
participants. The project advisor guided this process, as well as the site contact liaison. Once 
IRB approval was granted, the EBP project implementation was completed. The barriers to 
implementation were assessed both prior to, during, and after implementation. 
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 Phase 5-- evaluation. The evaluation stage involved examining the implementation and 
determining if the goals of the EBP project were met. The outcomes measured during the 
application phase were the number, type, and severity of the medication discrepancies and the 
total number of medication errors voluntarily reported. The first two outcomes would have ideally 
been collected using the EHR, however this was not possible. After detailed discussions with 
the information technology (IT) department is was determined that collecting the data from the 
EHR was not possible. In this case, the EHR did not provide the PL the ability to see who made 
Med Rec changes, what changes were made, and when the changes were made. Therefore, 
the data were collected by the physicians, at the project site, who conduct the last step in the 
Med Rec process and the PL. The physician’s evaluation served as an assessment of the 
information the MA or nurse entered into the EHR. The PL evaluation served as an assessment 
of the final Med Rec process product, ideally an accurate patient medication list. The third and 
final outcome was collected using the computer system, where medication errors are voluntarily 
reported. The number of reported medication errors during baseline data collection was 
compared to the number of reported medication errors post-intervention. 
 The goal of the EBP project intervention was to decrease the number of the medication 
discrepancies, decrease the severity of discrepancies, and decrease the number of medication 
errors. The Stetler Model guided the implementation of the intervention, with the goal of 
integrating the current evidence into current practice. The sustainability of the change in practice 
depended on the success of the EBP project intervention and outcome evaluation.  
Strengths and Limitations of EBP Model for EBP Project 
Strengths of the Stetler Model include a step-by-step approach to implementing 
evidence into practice. The step-by-step approach was extremely helpful to a novice EBP PL. 
The Stetler Model can be easily applied to a variety of practice areas and clinical problems. The 
visual flowchart and graph, that details the steps of EBP implementation, were helpful. The 
steps laid the foundation for successful EBP implementation. The foundation and focus of the 
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Stetler Model is critical thinking and using research findings to guide care, which was the 
ultimate goal of this EBP project.  
 The Stetler Model’s limitations are few, but could include the number of steps and also 
the complexity of each step. Although the visual representation of the model is helpful, the steps 
could be seen as overwhelming and laborious. Finally, the model flows in a linear pattern, and 
as discussed with the Kotter Model of Change, EBP implementation is complex. EBP change is 
set up for success if a theoretical framework and EBP model are used to facilitate the change. 
Literature Search 
Sources Examined for Relevant Evidence 
A thorough literature search was conducted to examine the evidence related to the 
identified clinical problem. The following databases were searched: Cumulative Index for 
Nursing and Allied Health (CINAHL), MEDLINE (via EBSCO), Nursing & Allied Health 
Database, Cochrane Library, Joanna Briggs Institute EBP Database (JBI), and the National 
Guideline Clearinghouse. The evidence was further narrowed using the limiters: English 
language, publication years 2006-2016, and scholarly (peer-reviewed) journals. A variety of 
search terms were trialed during the literature search and the final search terms included: 
“medic* reconcil*” AND (outpatient* OR “ambulatory care” OR “primary care” OR pediatric* OR 
infant* OR toddler* OR child* OR adolescen*). A list of the databases, search terms, search 
results, and applicable articles can be found in Table 2.1.  
 The search term “medic* reconcil*” was used to include articles that used the term 
“medication reconciliation” and also those that used the term “medicines reconcile.” The search 
terms “outpatient* OR “ambulatory care” OR “primary care” were used to focus the search on 
settings similar to the project site, an outpatient clinic. The goal of using these search terms was 
to eliminate inpatient studies. The search terms “pediatric* OR infant* OR toddler* OR child* OR 
adolescen*” allowed for the inclusion of studies with a population similar to the project site, 
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 Table 2.1 
Literature Search Results 
Database Search Terms Article Found Limiters Results Articles Used 
CINAHL 
 
“medic* reconcil*” 
AND (outpatient* OR 
“ambulatory care” OR “primary 
care” OR pediatric* OR infant* 
OR toddler* OR child* OR 
adolescen*) 
154  English language 
 Publication years 
2006-2016 
 Scholarly (peer-
reviewed) journals 
139 6 
MEDLINE 
(EBSCO) 
 
“medic* reconcil*” 
AND (outpatient* OR 
“ambulatory care” OR “primary 
care” OR pediatric* OR infant* 
OR toddler* OR child* OR 
adolescen*) 
344  English language 
 Publication years 
2006-2016 
 
326 2 
Nursing & 
Allied Health 
Database 
“medic* reconcil*” 
AND (outpatient* OR 
“ambulatory care” OR “primary 
care” OR pediatric* OR infant* 
OR toddler* OR child* OR 
adolescen*) 
16,096  English language 
 Publication years 
2006-2016 
 Scholarly (peer-
reviewed) journals 
 Search terms in 
abstract only 
63 0 
Cochrane 
 
medication reconciliation 4  Publication years 
2006-2016 
4 0 
JBI 
 
medication reconciliation 33  Publication years 
2006-2016 
33 0 
National 
Guideline 
Clearinghouse 
medication reconciliation 19  Not applicable 19 1 
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pediatrics. It is important to note that when the PL limited the search to studies involving Med 
Rec, the outpatient setting, and the pediatric population there were insufficient results. An 
example of the search that was found to be too narrow was “medic* reconcil*” AND (outpatient* 
OR “ambulatory care” OR “primary care”) AND (pediatric* OR infant* OR child* OR toddler* OR 
adolescen*). Therefore, the search was broadened to include articles that focused on the 
applicable setting and/or the applicable population. 
 After the initial database searches were completed, the results were reviewed for 
applicable articles. First, article titles were reviewed for applicability to the EBP project. 
Secondly, abstracts were reviewed. If the article abstract was unavailable, the full text version 
was found and reviewed for possible inclusion. Inclusion criteria included: Med Rec process 
specific, outpatient and/or pediatric focused, and interventions that included both the patient and 
the multidisciplinary healthcare team. Exclusion criteria included: adult inpatient focused and 
Med Rec completion as the only outcome. Furthermore, if an article abstract was deemed 
appropriate, the PL reviewed the full text of the article. Finally, the reference lists of applicable 
articles were reviewed in an effort to identify additional sources. 
 Eight articles were found to be applicable to the EBP project and met the inclusion 
criteria. Six articles were originally found in CINHAL and two in MEDLINE. No articles were 
originally found in Nursing & Allied Health Database, JBI, Cochrane, or in article reference lists. 
In addition to the eight articles, one clinical practice guideline (CPG) was found. The nine pieces 
of evidence were assigned levels of evidence and critically appraised to ensure that the 
literature review produced the best evidence regarding the topic, setting, and population. 
Levels of Evidence 
 The Stetler Model of EBP, specifically the third phase, was applied and articles were 
deemed usable, not usable, or possibly usable. Articles deemed usable were then thoroughly 
reviewed and assigned a level of evidence based on the Melnyk and Fineout-Overholt (2015) 
hierarchy of evidence. The Melnyk and Fineout-Overholt (2015) hierarchy of evidence consists 
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of seven levels, from I to VII. Level I evidence is from systematic reviews (SRs) or meta-
synthesis of all relevant randomized controlled trials (RCTs). Level II evidence is obtained from 
well-designed RCTs. To be deemed Level III evidence, the study must be a well-designed 
controlled trial without randomization. Level IV is evidence from well-designed case-control and 
cohort studies. Evidence is deemed to be Level V if it is from SRs of descriptive and qualitative 
studies. Level VI is evidence from single descriptive or qualitative studies. Finally, Level VII is 
evidence from the opinions of authorities and/or reports of expert committees. Level I is the 
highest level of evidence and Level VII is the lowest level of evidence (Melnyk & Fineout-
Overholt, 2015).   
The CPG in this review is based on SRs of RCT’s, single RCT’s, or observational 
studies when no RCTs were available, and is therefore Level I evidence (AHRQ, 2015). Six 
articles were found to be Level III, as they are quasi-experimental studies (Hron et al., 2015; 
Nassaralla et al., 2007; Nassaralla et al., 2009; Stock, Scott, & Gurtel, 2009; Varkey et al., 2007; 
Weingart et al., 2007). One article was deemed to be Level IV evidence, as it is a prospective 
cohort study (Huynh et al., 2016). Finally, one piece of Level VII evidence was obtained and is a 
review of literature (Huynh et al., 2013). 
Appraisal of Relevant Evidence 
The Johns Hopkins Research or Non-Research Appraisal Tool was used to determine 
the quality of the research evidence (Dearholt & Dang, 2012). This research tool contains a 
series of questions that guide the assessment of study quality. High quality is a consistent study 
with generalizable results. The sample size must be sufficient for the study design and adequate 
control must be demonstrated with definitive conclusions. Finally, a high quality study must have 
consistent recommendations, based on a comprehensive literature review that includes a 
thorough reference to scientific evidence. A study is considered good quality if there are: (a) 
reasonably consistent results, (b) sufficient sample size for the study design, (c) some control, 
(d) fairly definitive conclusions, (e) reasonably consistent recommendations, based on a fairly 
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comprehensive literature review, that includes some reference to scientific evidence. Low 
quality studies are studies with little evidence, inconsistent results, insufficient sample size for 
the study design, or if conclusions cannot be drawn (Dearholt & Dang, 2012).  
The Johns Hopkins Non-Research Appraisal Tool was used to determine the quality of 
the non-research evidence, specifically the CPG and the review of literature (AHRQ, 2015; 
Huynh et al., 2013). The tool contains a series of questions that guide the quality assessment; 
either high, good, or low quality (Dearholt & Dang, 2012). For a CPG to be considered high 
quality, it must be: (a) sponsored by a professional, public, private organization, or government 
agency, (b) document a systematic literature search strategy, (c) have consistent results, and 
(d) be developed or revised within the last five years (Dearholt & Dang, 2012). To be considered 
good quality, the CPG must be: (a) sponsored by a professional, public, private organization, or 
government agency, (b) document a reasonably thorough systematic literature search strategy, 
(c) have reasonably consistent results, and (d) be developed or revised within the last five years 
(Dearholt & Dang, 2012). Finally, to be considered low quality, the CPG must not: (a) be 
sponsored by an official organization, (b) document a systematic literature search strategy, (c) 
have consistent results, and (d) be developed or revised within the last five years (Dearholt & 
Dang, 2012).  
The guidelines for the quality of a review of literature differ, from the quality guidelines 
for a CPG. To be considered high quality, a review of literature must have definitive conclusions 
and scientific rationale (Dearholt & Dang, 2012). For a review of literature to be considered good 
quality, fairly definitive conclusions must be drawn and logical argument for opinions must be 
provided (Dearholt & Dang, 2012). Finally, low quality reviews do not provide conclusions 
(Dearholt & Dang, 2012). All evidence was kept regardless of the level or quality rating, as to 
represent the evidence that is currently available. Table 2.2 summarizes the evidence and 
provides both the level and quality rating for each piece of evidence.
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Table 2.2 
 
Methods Summary 
  
Authors 
Year Published 
 
Design 
Sample 
Outcome Intervention Results/Findings Level 
Quality 
Hron et al. 
 
2015 
 
 
Quasi-
experimental 
 
Quality 
Improvement 
 
Time-series 
 
Tertiary care 
children’s hospital- 
all patients 
admitted for one 
year 
Rate of non-
intercepted 
admission MREs, 
identified by a 
voluntary 
reporting system 
 
Severity of MREs:  
0-5 scale 
0= intercepted 
potential ADE’s 
(before reaching 
patient) 
1= non-
intercepted 
potential ADE 
(reached patient, 
no condition 
change) 
2= minor ADE 
3= moderate ADE 
4= major ADE 
5= catastrophic 
ADE 
 
EHR tool that 
displayed the pre-
admission 
medication list 
beside the 
admission 
medication orders 
 
Med Rec 
compliance was 
reported to 
inpatient units 
Med Rec tool was used in <3% of 
patients pre-intervention and in 
83.8% of patients post-intervention 
 
MRE’s:  
Pre-intervention: 4.1 errors per 
1,000 admissions 
Post-intervention: 2.0 errors per 
1,000 admissions 
Statistically significant decrease 
(53%) in rate of MRE’s post 
intervention (p = .02; 95% CI [26, 
87]) 
 
Risk of reported ADEs related to 
admission Med Rec was 
significantly lower post intervention 
(R2 = .24; p < .001; 95% CI [0.11, 
0.53]) 
 
Severity: 
Intercepted potential ADEs (35% of 
total errors) 
Pre-intervention: 1.7 per 1,000 
admissions 
Post-intervention: 1.4 per 1,000 
admissions 
 
Level: III 
 
Quality: 
High 
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Non-intercepted potential ADEs 
(42% of total errors) 
Pre-intervention: 2.3 per 1,000 
admissions 
Post-intervention: 1.5 per 1,000 
admissions 
 
Minor ADEs (22% of total errors) 
Pre-intervention: 1.7 per 1,000 
admissions 
Post-intervention: 0.4 per 1,000 
admissions 
 
Moderate ADEs (1% of total errors) 
0.1 errors both pre and post-
intervention 
 
No major or catastrophic ADE’s pre 
or post-intervention 
Huynh et al.  
 
2013 
 
 
Review of 
Literature, without 
meta-analysis 
 
Literature search 
of PubMed, OVID 
EMBASE, ISI Web 
of Science, ISI 
Biosis, CINHAL, 
and OVID 
International 
Pharmaceutical 
Abstracts 
 
Inclusion criteria:  
< 18 years of age 
upon admission to 
Medication 
discrepancy at 
pediatric 
transitions of care 
 
Clinical 
significance of 
discrepancy  
 
Type of 
discrepancy 
 
Intervention used 
specified 
Pharmacy 
computer system 
that generates a 
complete and 
accurate Med Rec 
form to serve as a 
transfer order 
 
BPMH form that 
physicians were 
expected to 
complete, nurses 
completed Med 
Rec if <4 
medications, if >4 
medications 
pharmacist 
No uniform outcome was used to 
measure effect of Med Rec in the 
pediatric population 
 
There is little information or data on 
using Med Rec in the pediatric 
population 
 
Using Med Rec in pediatrics, to 
improve medication safety, is 
challenging 
 
Further research is needed to fully 
understand the most beneficial Med 
Rec process in pediatrics 
Level: 
VII 
 
Quality: 
High 
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hospital, transfer, 
or discharge, and 
reported Med Rec 
intervention 
 
Exclusion criteria: 
mixed pediatric 
and adult data that 
could not be 
stratified, outside 
pediatric age limit, 
not original 
research, did not 
clearly define 
discrepancies or 
intervention 
 
10 sources 
6 prospective 
observational 
studies, 4 
retrospective 
observational 
studies 
 
7 full articles, 
3 non-peer 
reviewed, 
conference 
abstracts 
 
completed Med 
Rec 
 
Student 
pharmacist 
formulated BPMH 
 
BPMH list 
compiled using 
five sources on 
admission 
 
Pharmacist 
complied 
independent 
medication history 
upon admission 
and transfer 
 
Best possible 
medication 
discharge plan 
was used at 
patient’s discharge 
 
Introduction of 
pharmacist in a 
pediatric ER 
 
4 stage Med Rec 
by pharmacist  
Huynh et al. 
 
2016 
 
 
Prospective 
Cohort 
 
Medication 
discrepancies= 
difference 
between pre-
admission 
Clinical pharmacist 
1. Interviewed 
caregiver 
2. Called PCP to 
obtain 
Overall, 1004 individual 
prescriptions: 
582 medication discrepancies/1004 
prescriptions (58%), affecting 203 
patients (83%) 
Level: IV 
 
Quality: 
High 
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4 pediatric 
hospitals in the 
United Kingdom 
 
Inclusion criteria: 
one long term 
medication 
prescribed 
 
Exclusion criteria: 
no long term 
medications 
prescribed,  > 19 
years of age, 
caregiver not 
present, drug list 
not available, or 
admitted outside 
of routine hours 
 
n = 244 
medication list 
when compared 
to initial 
admission 
medication orders 
 
Intentional vs. 
unintentional 
discrepancies 
 
Severity of 
unintentional 
discrepancies:  
Class 1: 
potentially minor 
Class 2: 
potentially 
moderate 
Class 3: 
potentially severe 
 
Time needed to 
complete Med 
Rec was 
recorded 
medication 
record 
3. Recorded 
patients 
medications 
brought from 
home 
4. Examined 
initial 
admission 
medication 
orders 
 
No previous Med 
Rec process was 
in place 
209/582 unintentional 
discrepancies, affecting 109/244 
patients (45%) 
277/582 (48%) intentional 
discrepancies 
96/582 (16%) discrepancies were 
determined to be trivial or related to 
nutrition 
 
Severity: 
Class 1: 22% of unintentional 
medication discrepancies 
Class 2: 50% of unintentional 
medication discrepancies 
Class 3: 28% of unintentional 
medication discrepancies 
 
Total time needed to complete the 
Med Rec: 6-144 minutes (Mdn = 24, 
IQR = 17-40) 
 
Parents/caregivers were the most 
accurate source (81% correct) 
compared to the pharmacist 
completed regimen 
 
Medications were present at 38.5% 
of admissions 
Nassaralla et al. 
 
2007 
 
 
Quasi-
experimental 
Before and after 
 
Adult primary care, 
internal medicine 
clinic 
 
Completeness of 
Med Rec in EHR 
(“complete”= 
name, dose, 
frequency, and 
route 
documented) 
 
Reviewed process 
and shared data 
with team 
members 
 
2 steps: 
1. Educated all 
team members 
Significant increase in 
documentation of dose and route 
Pre-intervention: 27.4% missing 
dose, 85.8% missing route 
Post-intervention: 21.7% missing 
dose, 16.8% missing route (p < .03) 
Sustainability: 12.9% missing dose, 
13.1% missing route (p < .001) 
Level: III 
 
Quality: 
Good 
 
MEDICATION RECONCILIATION  30  
 
Pre-intervention:  
n = 65 
 
Post-intervention: 
n = 100 
 
Sustainability 
phase: n = 65 
 
Correctness of 
Med Rec in EHR 
(“correct”= no 
discrepancies in 
the name, dose 
frequency, or 
route, between 
the med list in 
EHR and the 
medications the 
patient was taking 
at home) 
 
Phone call to 
collect 
information from  
patient 
 
Accurate = 
complete and 
correct Med Rec 
 
what constitutes a 
complete and 
correct medication 
list, shared results 
of pre-intervention 
data with nurses 
and physicians, 
same Med Rec 
review process for 
all patients (LPN 
obtained and 
documented 
medication history 
in EHR) 
 
2.Revamped 
entire visit, 
educated each 
team member on 
role in improving 
completeness and 
correctness, 
patient reminded 
to bring 
medications or 
updated list to 
visit, when patient 
arrived they were 
given a form to 
record 
medications if they 
did not bring 
containers or list, 
LPN recorded all 
four components 
of each 
 
Correctness: 
Pre-intervention: 59/86 (69%) of 
patients agreed to participate 
Post-intervention: 61/100 (61%) of 
patients agreed to participate 
 
No significant improvement of 
correctness (p = 0.442):  
Pre-intervention: 14/59 (23.7%) 
Post-intervention: 11/61 (18%)  
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medication, 
physician 
reconciled and 
updated the list, 
transcriptionist 
checked for 
discrepancies 
between the 
dictation and the 
med list in the 
EHR 
Nassaralla et al.  
 
2009 
 
 
Quasi- 
experimental 
Before and after 
 
4 adult ambulatory 
primary care 
internal medicine 
clinics 
 
Pre-intervention:  
n = 108 
 
LPN intervention: 
n = 102 
 
Patient 
intervention:  
n = 115 
Completeness of 
Med Rec in EHR 
(“complete”= 
name, dose, 
frequency, and 
route 
documented) 
 
Correctness of 
Med Rec in EHR 
(“correct”= no 
discrepancies in 
the name, dose 
frequency, or 
route, between 
the medication list 
in EHR and 
medications the 
patient was taking 
at home) 
 
Phone call to 
collect 
information from 
patient  
3 phases: 
1.Baseline data 
 
2.LPN 
intervention:  
(a) education 
including the 
complete and 
correct Med Rec 
process, 
(b) performance 
updates including 
number and type 
of discrepancies 
 
3.Patient 
awareness:  
(a) called day 
before visit 
(b) highlighted 
paragraph in 
reminder letter 
than was focused 
on bringing 
Statistically significant increase in 
the number of complete individual 
medications and lists (p <. 03): 
Complete medication list: 
Pre-intervention: 22/108 (20.4%) 
LPN-intervention: 46/102 (45.1%) 
Patient-intervention: 58/115 (50.4%) 
Complete medications: 
Pre-intervention: 605/791 (76.5%) 
LPN-intervention: 643/759 (84.7%) 
Patient-intervention: 781/885 
(88.3%) 
 
Correctness: 
Participation 
Pre-intervention: 61/108 (56%) of 
patients in correctness assessment 
LPN-intervention: 52/102 (51%) of 
patients in correctness assessment 
Patient-intervention: 69/115 (60%) 
of patients in correctness 
assessment 
 
There was a decrease in 
correctness from 19/61 (31.2%) in 
Level: III 
 
Quality: 
High 
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Accurate= 
complete and 
correct 
 
medications to 
appointment 
(c) brochure in 
waiting room 
(d) LPN educated 
patient on 
importance of Med 
Rec 
(e) given copy of 
brochure 
(f) reconciled 
medications 
(g) printed copy 
and gave to 
patient 
 
the pre-intervention phase to 12/52 
(23.1%) in the LPN intervention 
phase (p < .34) 
 
Patient-intervention increased 
correctness from 12/52 (23.1%) in 
the LPN intervention phase to 26/69  
(37.7%) in the patient intervention 
phase (p = .087) 
 
Accuracy significantly improved 
from pre-intervention phase to the 
patient intervention phase from 
11.5% to 29% (p = .014) 
 
Percentage of patients that brought 
their medications increased from 
13.9% in the pre-intervention phase 
to 33% in the patient intervention 
phase (p < .001) 
National Institute 
for Health and 
Care Excellence 
(NICE) 
 
2015 
 
 
SR of SRs of 
RCTs, single 
RCTs, or 
observational 
studies (when 
RCTs were not 
available) 
 
Individuals using 
medications 
  
Improved 
medication safety 
Med Rec 
completed by a 
trained 
professional 
Med Rec should be completed at all 
transitions of care 
 
In the hospital setting, Med Rec 
should be documented within 24 
hours of admission and when the 
person moves from one setting to 
another, for example transfers 
between units 
 
In primary care, Med Rec should be 
completed on every patient 
discharged from the hospital or 
seeking care from another facility 
 
Level I 
 
Quality: 
High 
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Trained professionals were defined 
as a pharmacist, pharmacy 
technician, nurse, or physician 
 
It is important to involve patients 
and their families in the Med Rec 
process 
 
Med Rec should be performed using 
a designated process, in which the 
medications are recorded in an EHR 
or on paper 
Stock et al. 
 
2009 
 
 
Quasi-
experimental  
Before and after 
 
11 primary care 
clinics 
Number of 
inaccurate EHR 
medication lists 
 
 
5 components: 
 
1. Asked patient to 
bring medications 
to visit during 
appointment 
reminder call 
 
2. Clinic personnel 
reviewed 
medications with 
the patient at start 
of  visit 
 
3. Medication list 
was reconciled 
with EHR and 
changes were 
documented 
 
4. New 
prescriptions were 
checked for 
interaction/conflict, 
Baseline: 20% of the reviewed 
charts has discrepancies between 
the EHR and the patient’s 
medication list. 
Post-intervention: 50% of the 
reviewed charts has discrepancies 
between the EHR and the patient’s 
medication list 
 
Number of discrepancies per 
medication list was reduced 
significantly (no statistical data 
provided) 
Level: III 
 
Quality: 
Poor 
 
MEDICATION RECONCILIATION  34  
 
with an updated, 
reconciled 
medication list 
 
5. A printed paper 
copy of the 
reconciled 
medication list was 
given to the 
patient  
Varkey et al. 
 
2007 
 
 
Quality 
Improvement 
Quasi-
experimental 
Before and after 
 
104 primary care 
patients 
 
Phase I (pre-
intervention): 
n = 54 
 
Phase II (post-
intervention): 
n = 50 
Number of 
medication 
discrepancies 
between what the 
patient was taking 
and what the 
EHR stated the 
patient was taking 
 
Severity of 
discrepancies: 
Minor- incomplete 
information in 
medication order, 
unavailable or 
inappropriate 
dosage form, 
non-formulary 
drug, or unusable 
abbreviation 
Significant- high 
dosage (1.5-4 
time normal) of 
drug with low 
therapeutic index, 
drug dosage too 
Phase I:  
(pre-intervention, 
standard care) 
Medication history 
was documented 
in the EHR by the 
provider 
 
Phase II: 2 levels 
1. Patient level:  
(a) reminder letter 
to bring 
medication bottles 
to next visit was 
mailed to the 
patient 
(b) the patient 
verified and 
corrected the 
medication list in 
the EHR 
 
2. Provider level: 
(a) education 
including 
significance and 
Patients brought their medication 
bottles or an updated list: 
Phase I: 3/54 (5%) of patients 
Phase II: 26/50 (52%) of patients 
 
Visits with some EHR medication 
discrepancy (p = .0134): 
Phase I: 53/54 (98.2%)  
Phase II: 42/50 (84%) 
 
Medication lists with discrepancy 
(when prescription medications only 
considered) (p = .005): 
Phase I: 48/54 (88.9%) 
Phase II: 33/50 (66%) 
 
Total individual prescription 
medications with discrepancies: 
Phase I: 177/200 (88.5%) 
Phase II:79/161 (49.1%) 
Incorrect or missing route was the 
most common missing information 
 
Average number of discrepancies 
among herbal and OTC 
medications: 
Level: III 
 
Quality: 
Good 
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low for patient’s 
condition, 
incorrect dual 
drug therapy for 
single condition, 
inappropriate 
dosage interval, 
or omission from 
medication order 
Serious- route of 
administration 
could lead to 
toxicity, low 
dosage of drug 
for serious 
disease, drug 
could worsen 
patient’s 
condition, 
misspelling that 
could lead to 
dispensing 
incorrect drug 
Potentially lethal- 
high potential for 
life-threatening 
adverse 
reactions, 
potentially 
lifesaving drug at 
a dosage that is 
too low, high 
dosage of drug 
with low 
therapeutic index 
method of the Med 
Rec 
(b) audit feedback 
weekly via email 
with examples of 
errors and 
individual data 
compared to 
others 
 
Phase I: 112/147 (76.2%) 
Phase II: 34/101 (33.7%) 
 
Severity: 
Minor 
Phase I: 75% 
Phase II: 82.9% 
Significant 
Phase I: 24% 
Phase II: 17% 
Serious 
Phase I: 0.3% 
No lethal discrepancies in Phase I 
or Phase II 
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Weingart et al.  
 
2007  
 
 
Quasi-
experimental 
Before and after 
Quality 
Improvement  
 
2 adult outpatient 
oncology clinics 
  
1 pediatric 
outpatient 
oncology clinic, 
data cannot be 
stratified 
 
Standard care 
group: 
n = 54 
 
Intervention group: 
n = 50 
 
Number of 
medication lists 
reconciled 
  
Errors and 
omissions per 
patient and per 
prescription 
 
Pharmacist time 
required to collect 
Med Rec lists and 
correct EHR’s 
 
Copy of 
medication list and 
a one page cover 
letter 
 
Standard care 
group: list was 
collected prior to 
appointment 
 
Intervention group: 
(a) took updated 
list into 
appointment 
(b) brochure sent 
about medication 
safety 
(c) printed copy 
from EHR given to 
patient at visit 
(d) asked patient 
to update, 
including OTC, 
vitamins, and 
supplements 
(e) physician 
reviewed the list 
with the patient 
(f) the physician or 
pharmacist 
updated the EHR 
(g) printed 
updated med list 
given to patient 
The number of medication lists 
reconciled per month increased 
>400% from 300-400 per month in 
the pre-intervention phase to 1500-
2000 per month in the post-
intervention phase 
 
53,040 changes to 168,475 listed 
drugs (31 changes per 100 
medications) (81% of patients list 
included at least one error or 
omission) 
 
257 hours/year (0.6 full-time 
equivalents of a pharmacist’s time) 
 
Medication list that had at least one 
patient identified correction (p < 
.001): 
Standard care group: 1/47 (2%) 
Intervention group: 38/42 (90%) 
 
Number of physician made changes 
per patient (p < .001): 
Standard care group: 0.1 changes 
per patient 
Intervention group: 4.3 changed per 
patient 
 
Level III 
 
Quality: 
Good 
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Note. MRE= medication reconciliation errors, ADE= adverse drug event, EHR= electronic health record, Med Rec= medication 
reconciliation, BPMH= best possible medication history, ER= emergency room, PCP= primary care provider, LPN= licensed practical 
nurse, SR= systematic reviews, RCT= randomized controlled trials, OTC= over-the-counter.
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Construction of Evidence-based Practice 
The literature was examined and only literature relevant to the topic was included. The 
inclusion and exclusion criteria guided the systematic literature review. Articles that were 
deemed applicable were then leveled and appraised to ensure that the best Med Rec practice 
was identified. A single article was found that examined Med Rec in the pediatric outpatient 
oncology setting (Weingart et al., 2007). The CPG found addressed Med Rec in any setting and 
was included as a baseline recommendation. The remaining literature was divided into three 
main groups: pediatric inpatient studies, adult outpatient studies, and adult inpatient studies. 
The pediatric inpatient and adult outpatient studies became the focus of the literature review, as 
their setting or population were similar to the project site. Adult inpatient studies were not 
included because the setting and the population differed from the project site’s setting and 
population. Also, the Med Rec process and outcomes were not applicable to this project.  
 Pediatric and adult outpatient oncology study and CPG. As discussed previously, a 
minimal amount of literature, examining the implementation or improvement of the Med Rec 
process, in the pediatric outpatient setting was discovered. The CPG, along with the study that 
examined improving the Med Rec process, in both a pediatric and an adult outpatient oncology 
setting are discussed (AHRQ, 2015; Weingart et al., 2007). 
 Level I evidence. In 2015, the National Institute for Health and Care Excellence (NICE) 
developed a CPG entitled “Medicines Optimization: The Safe and Effective Use of Medicines to 
Enable the Best Possible Outcomes.” The guideline is based on a systematic review of SRs of 
RCTs, single RCTs, or observational studies (when RCTs were not available). The guideline is 
applicable to “all children, young people, and adults using medications,” with a goal of improving 
medication safety (AHRQ, 2015, p. 1). The guideline recommends that Med Rec be completed 
by a trained professional, at all transition of care. A trained professional was defined as a 
pharmacist, pharmacy technician, nurse, or physician. The CPG formulated many conclusions, 
the conclusions applicable to the project have been reviewed. The guideline emphasizes the 
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importance of involving patients and their families in the Med Rec process. Also, the CPG 
recommends Med Rec be performed using a designated process, in which medications are 
recorded in an EHR or on paper (AHRQ, 2015). 
Level III evidence. A quasi-experimental, before and after, study was conducted at one 
pediatric outpatient oncology clinic and two adult outpatient oncology clinics (Weingart et al., 
2007). Unfortunately, the data could not be stratified from the information provided. The 
standard care group (n = 54) received a copy of their medication list and were asked to revise 
the medication list. The list was then collected prior to the physician aspect of the appointment. 
In contrast, the intervention group (n = 50) was sent a brochure about medication safety. Upon 
arriving to their visit, the patient was given a printed medication list from the EHR and asked to 
update the list. The patient was instructed to include: OTC medications, vitamins, and 
supplements. During the visit, the physician reviewed the list with the patient, and the physician 
or pharmacist updated the EHR. Finally, the updated medication list was printed and given to 
the patient, prior to the end of the visit (Weingart et al., 2007).  
The number of medication lists that were reconciled, along with the errors and omissions 
per patient and per prescription were recorded. The number of medication lists reconciled 
increased greater than 400% from 300-400 per month in the pre-intervention phase to 1,500-
2,000 per month in the post-intervention phase. There were 53,040 changes to 168,475 listed 
drugs (31 changes per 100 medications) and 81% of patients’ lists included at least one error or 
omission. Two-hundred and fifty seven hours per year (0.6 full-time equivalents of a 
pharmacist’s time) was needed to collect the Med Rec lists and correct the EHR. The number of 
medication lists, that had at least one patient identified correction, increased from 2% (one of 
47) in the standard care group to 90% (38 of 42) in the post-intervention group (p < .001). The 
number of ‘physician made’ changes per patient increased from 0.1 changes per patient in the 
standard group to 4.3 changes per patient in the intervention group (p < .001) (Weingart et al., 
2007). 
MEDICATION RECONCILIATION  41  
 
Pediatric inpatient studies. The evidence, included in this review of literature, that 
focused on the pediatric inpatient population are of particular importance. Specifically, they 
discuss the need for Med Rec in pediatrics. Med Rec should be viewed as a way to decrease 
the incidence of medication errors. Pediatric patients are at an increased risk for medication 
errors; and therefore, techniques for possible reduction in errors should be taken seriously. The 
pediatric inpatient evidence focused on both the completion of the Med Rec process and the 
accuracy of the Med Rec. One Level III study, one Level IV study, and one Level VII review of 
literature were included and are discussed at this time. 
 Level III evidence. Hron et al. (2015) conducted a study that sought to “measure the 
impact of electronic medication reconciliation implementation on reports of admission 
medication reconciliation errors (MREs)” (p. 314). The quasi-experimental, quality improvement, 
time series was conducted at a tertiary care children’s hospital and included all patients 
admitted in one year. The outcome of measure was the rate of non-intercepted admission 
MREs identified, by a voluntary reporting system. The severity of the MREs was ranked on a 
zero to five scale: zero was assigned to any intercepted potential ADE that did not reach the 
patient; one was assigned to any non-intercepted potential ADE that reached the patient and no 
condition change occurred; two was any minor ADE; three was any moderate ADE; four was 
any major ADE; and five was any catastrophic ADE. The intervention implemented was an EHR 
tool that displayed the pre-admission medication list beside the admission medication orders. 
Also, Med Rec compliance was reported to the inpatient units (Hron et al., 2015).  
The Med Rec tool compliance was found to be <3% pre-intervention and 83.8% post-
intervention. Pre-intervention there were 4.1 Med Rec errors per 1,000 admissions and post-
intervention there were 2.0 errors per 1,000 admissions. There was also a statistically significant 
decrease (53%) in rate of MRE’s post intervention (p = .02; 95% CI [26, 87]). The risk of 
reported ADEs related to admission Med Rec was significantly lower post intervention (R2 = .24; 
p < .001; 95% CI [0.11, 0.53]). Pre-intervention there were 1.7 intercepted potential ADEs, per 
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1,000 admissions and 1.4 post-intervention. There were 2.3 non-intercepted potential ADEs, per 
1,000 admissions pre-intervention and 1.5 post-intervention. Minor ADEs were reported as 1.7, 
per 1,000 admissions pre-intervention and 0.4 post-intervention. Moderate ADEs were 0.1, per 
1,000 admissions both pre- and post-intervention. During the study period there were no major 
or catastrophic ADE’s pre- or post-intervention. Overall, the Med Rec process produced a 
statistically significant decrease in the reported number of non-intercepted admission MREs, 
after an electronic Med Rec process was implemented (Hron et al., 2015). 
 Level IV evidence. A prospective cohort study, by Huynh et al. (2016), conducted in 
four pediatric hospitals in the United Kingdom, examined the incidence of unintended 
medication discrepancies, in pediatric inpatients. The authors included patients (n = 244) if they 
were prescribed one long term medication. They excluded patients if they were: > 19 years of 
age, had no caregiver present, no drug list was available, or if they were admitted outside of 
routine hours. Medication discrepancies, defined as a difference between the patients pre-
admission medication list when compared to initial admission medication orders, were totaled 
and classified as intentional or unintentional. The severity of unintentional discrepancies was 
further classified as: class 1 potentially minor, class 2 potentially moderate, and class 3 
potentially severe. Finally, the time to obtain information was recorded. In this study, a clinical 
pharmacist: (1) interviewed the caregiver, (2) called the PCP to obtain the patients medication 
record, (3) recorded the patients medications brought from home, and (4) examined the initial 
admission medication orders. There was no previous Med Rec process in place at this site 
(Huynh et al., 2016).  
Overall, there were 1,004 individual prescriptions and 582 medication discrepancies 
(58%) that affected 203 patients (83%). Two hundred and nine of those discrepancies were 
unintentional and affected 109 patients (45%). Two hundred and seventy-seven of the 
discrepancies were intentional, and 96 were determined to be trivial or related to nutrition. 
Twenty-two percent of the unintentional medication discrepancies were class 1; 50% were class 
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2; and 28% were class 3. The total time to collect the information ranged from six to 144 
minutes (Mdn = 24, IQR 17-40) (Huynh et al., 2016).  
The authors found that the parents/caregivers were the most accurate source, with 81% 
correct when compared to the pharmacist completed regimen. The PCP was 70% correct, 
followed by the medications present at the visit with 56% correct. The medications were brought 
with the patients at 38.5% of admissions. The authors postulated that Med Rec decreased the 
risk of harm from unintended medication discrepancies. Parents were found to be the most 
sensitive/accurate source of information, followed by the PCP, and then the medications present 
(Huynh et al., 2016). 
 Level VII evidence. A review of literature, without meta-analysis, conducted by Huynh et 
al. (2013), focused on the rate of medication discrepancies in pediatric patients at transitions of 
care and specifically what Med Rec interventions were being used. The authors searched 
numerous databases including: PubMed, OVID EMBASE, ISI Web of Science, ISI Biosis, 
CINHAL, and OVID International Pharmaceutical Abstracts. Inclusion criteria included: < 18 
years of age upon admission to the hospital, transfer, or discharge, and a reported Med Rec 
intervention. Exclusion criteria included: mixed pediatric and adult data that could not be 
stratified, outside the pediatric age limit, not original research, and studies that did not clearly 
define discrepancies or interventions (Huynh et al., 2013).  
In total, ten articles were included in the review: six prospective observational studies 
and four retrospective observational studies. There were seven full articles and three non-peer 
reviewed articles. The outcomes of focus were medication discrepancies, at pediatric transitions 
of care, and the clinical significance of the identified discrepancies. The majority of 
measurements occurred upon inpatient hospital admission. The slight variance in the outcome 
measurement limits the generalizability to other populations (Huynh et al., 2013). 
The review of literature uncovered a variety of interventions that were used in an effort to 
increase Med Rec accuracy. The variety of interventions did not lead to definitive conclusions, 
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regarding the best practice to increase Med Rec accuracy. The authors concluded that there 
was limited high quality evidence related to Med Rec, at pediatric transitions of care. Further 
research is needed to fully understand the most beneficial Med Rec process in pediatrics 
(Huynh et al., 2013). 
 Adult outpatient studies. Four of the sources, included in this review of literature, all 
Level III, focused on Med Rec in the adult outpatient setting. Common themes were found in 
these adult outpatient studies. Themes included (a) a Med Rec process that is complete, 
correct, and accurate, (b) the importance of a multidisciplinary approach, and (c) an intervention 
that included both patient and provider. 
 Level III evidence. Nassaralla et al. (2007) conducted a quasi-experimental, before and 
after, study in an adult primary care, internal medicine clinic. Pre-intervention there were 65 
participants, post-intervention there were 100 participants, and during the sustainability phase 
there were 65 participants. The outcome of measure was the completeness of Med Rec in the 
EHR. Completeness was defined as a medication having the name, dose, frequency, and route 
of administration documented in the EHR. Also, the correctness of the Med Rec in EHR was 
assessed. Correctness occurred when there were no discrepancies in the name, dose, 
frequency, or route of administration between the medication list in EHR and the medications 
the patient was taking at home. The correctness was evaluated by contacting the patients via 
phone and verifying the current medication regimen. Finally, a Med Rec was deemed accurate if 
it was both complete and correct (Nassaralla et al., 2007).  
Prior to the intervention, the authors reviewed the Med Rec process and shared the 
collected baseline data, with team members. The intervention consisted of two steps. In the first 
step, all the team members were educated, regarding what constitutes a complete and correct 
medication list. The results of the pre-intervention data were shared with the nurses and 
physicians. The same rooming process was used for all patients. The rooming process 
consisted of the LPN obtaining and documenting the medication history in the EHR. The second 
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step was to revamp the entire patient visit. First, team members were educated on their role in 
the Med Rec process. The patients were reminded to bring their medications or an updated list 
to their visit. When the patient arrived they were given a form to their record medications, if they 
had not brought their medication containers or a list. The LPN recorded all four components of 
each medication. Then the physician reconciled and updated the list. Finally, the transcriptionist 
checked for discrepancies between the dictation and the EHR medication list (Nassaralla et al., 
2007).  
The authors found a significant increase in the documentation of the dose and route. In 
the pre-intervention phase, 27.4% of medications charted were missing a dose, post-
intervention that percentage had decreased to 21.7 (p < .03). During, the sustainability phase 
the percentage of medications without a dose charted was 12.9%, this was a statistically 
significant improvement from the post-intervention phase (p < .001). In the pre-intervention 
phase 69% (59 of 86) of the patients agreed to participate in the correctness interview. Post-
intervention 61% (61 of 100) agreed to participate. There was no significant improvement of 
medication list correctness found pre-intervention (23.7%), when comparted to the post-
intervention phase (18%) (p = .442) (Nassaralla et al., 2007). 
 The second Level III evidence was a quasi-experimental, before and after, study 
(Nassaralla et al., 2009). The setting was four adult ambulatory, primary care, internal medicine 
clinics. The intervention consisted of three phases: pre-intervention/baseline data collection (n = 
108), an LPN intervention phase (n = 102), and a patient awareness intervention phase (n = 
115). The completeness, correctness, and accuracy of the medication list, where the outcomes 
examined. Completeness was defined as a medication having the name, dose, frequency, and 
route of administration documented in the EHR. Correctness occurred when there were no 
discrepancies in the name, dose, frequency, or route of administration between the medication 
list in EHR and the medications the patient was taking at home. The correctness was evaluated 
MEDICATION RECONCILIATION  46  
 
by contacting the patients via phone and verifying the current medication regimen. Finally, a 
Med Rec was deemed accurate if it was both complete and correct (Nassaralla et al., 2009).  
First, the authors collected pre-intervention, baseline data on 108 patients. The data 
included the completeness, the correctness, and accuracy of the medication list. The authors 
then provided an LPN intervention. The LPN intervention consisted of education including the 
complete and correct Med Rec process and performance updates including the number and 
type of discrepancies. The patient awareness intervention consisted of: (a) calling the patient 
the day before a their visit and reminding them to bring their medications with them, (b) 
highlighting the paragraph in the reminder letter that focused on bringing medications to the 
appointment, (c) a brochure in waiting room that emphasized medication safety importance, (d) 
the LPN educated the patient on the importance of Med Rec (e) a copy of the brochure was 
given to the patient (f) the medications were reconciled, and (g) a printed copy was given to the 
patient (Nassaralla et al., 2009).  
There was a statistically significant increase in the number of medications and lists that 
were completed (p < .03). Pre-intervention 20.4% of medication lists were complete, after the 
LPN intervention 45.1% of lists were complete, and after the patient awareness intervention 
50.4% of lists were complete. Pre-intervention 76.5% of medications documented were 
complete, after the LPN intervention 84.7% of medications documented were complete, and 
after the patient awareness intervention 88.3% of medications documented were complete. The 
participation in the assessment of correctness was 56% pre-intervention, 51% after the LPN 
intervention, and 60% after the patient awareness intervention. From the pre-intervention to 
LPN intervention statistically significant improvement was not shown. Actually, there was a 
decrease in correctness from 31.2% in the pre-intervention phase to 23.1% in the LPN 
intervention phase (p < .34). The authors speculated that this is a result of the small number of 
participants that agreed to participate in the correctness assessment, or possibly a result of the 
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pressure LPNs felt to complete the medication list, disregarding the correctness (Nassaralla et 
al., 2009).  
The patient participation component increased correctness from 23.1% in the LPN 
intervention phase to 37.7% in the patient intervention phase (p = .087). Accuracy was 
significantly improved from the pre-intervention phase to the patient intervention phase from 
11.5% to 29% (p = .014). The percentage of patients that brought their medications increased 
from 13.9 % to 33% in the pre-intervention phase to the patient intervention phase (p < .001). 
Overall, the increased team member and patient participation lead to an increase in the 
completeness of medications documentation and medication lists (Nassaralla et al., 2009). 
 A quasi-experimental, before and after, study took place in 11 primary care clinics (Stock 
et al., 2009). The number of inaccurate EHR medication lists and medication accuracy were 
measured. There were five components to the Med Rec implementation. The first step was 
asking the patient to bring their medications to their visit. This reminder occurred during the 
appointment reminder call. Secondly, the clinic personnel reviewed the patient’s medications at 
the start of the visit. Next, the medication list was reconciled in the EHR and changes were 
documented. The fourth step was that new prescriptions were checked for interaction or conflict 
with the updated reconciled medication list. Finally, a printed paper copy of the reconciled 
medication list was given to the patient (Stock et al., 2009).  
Despite the five components of the Med Rec process being implemented, the authors 
noted that “it was not stipulated that the implementation needed to be the same at each practice 
setting, thereby allowing practices to design a process that took into account their personnel 
and resources without affecting the agreed-on outcome of more accurate medication lists” 
(Stock et al., 2009, p. 276). Stock et al. (2009) concluded that the Med Rec process showed a 
“substantial increase in the number of accurate medication lists, with fewer discrepancies 
between what the patient is taking and what is recorded in the EMR” (p. 271). Prior to the 
intervention 20% of the reviewed charts has discrepancies between the EHR and the patient’s 
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medication list. Post-intervention 50% of the reviewed charts has discrepancies between the 
EHR and the patient’s medication list. No additional data could be extrapolated from the article 
(Stock et al., 2009).  
 The fourth Level III source of evidence focused on Med Rec in the adult outpatient 
setting. The authors conducted a quasi-experimental, before and after study, that involved 104 
primary care patients (Varkey et al., 2007). The study was divided into Phase I (pre-intervention, 
n = 54) and Phase II (post-intervention, n = 50). The number of medication discrepancies 
between what the patient was taking and what the EHR stated the patient was taking were 
recorded. The severity of the discrepancies were classified as minor, significant, serious, or 
potentially lethal. During Phase I, standard care was provided to the patients, in which the 
medication history was documented in the EHR by the provider. In Phase II, there was a patient 
level intervention and a provider level intervention. The patient level intervention included: (a) a 
mailed, reminder letter to bring medication bottles to the next visit and (b) verification and 
correction of the medication list in the EHR by the patient. The provider level intervention 
included: (a) education including the significance and method of Med Rec and (b) audit 
feedback weekly via email, with examples of errors and individual data compared to others 
(Varkey et al., 2007).  
Five percent of patients (3 of 54) brought their medication bottles in Phase I, as 
compared to 52% (26 of 50) in Phase II. In Phase I, 98.2% (53 of 54) of visits had some EHR 
medication discrepancy and in Phase II 84% (42 of 50) had a discrepancy (p = .0134). When 
only prescription medications were considered, the medication lists with discrepancies were 
88.9% (48 of 54) in Phase 1 and 66% (33 of 50) in Phase II (p = .005). The number of 
discrepancies per patient decreased from 5.24 in Phase I to 2.46 in Phase II. The total individual 
prescription medications with discrepancies was 88.5% (177 of 200) in Phase I and 49.1% (79 
of 161) in Phase II. Incorrect or missing route was the most common missing information. The 
average number of discrepancies among herbal and OTC medications was 76.2% (112 of 147) 
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in Phase I and 33.7% (34 of 101) in Phase II. Seventy-five percent of the discrepancies were 
minor in Phase I and 82.9% were in Phase II. The percentage of significant discrepancies 
decreased from 24% in Phase I to 17% in Phase II. In Phase I, there was one serious 
discrepancy and no lethal discrepancies in either phase (Varkey et al., 2007). According to 
Varkey et al. (2007), “a multifaceted intervention including various members of the health care 
provider team and the patient is crucial to enhancing medication reconciliation in the outpatient 
setting” (p. 291).    
Synthesis of Critically Appraised Literature 
The synthesized literature provided common themes, in regards to the Med Rec 
process, measureable outcomes, and interventions. All the evidence emphasized the 
importance of having a standardized Med Rec process that is clear and communicated to all 
team members and patients. The outcome used most frequently in the literature was the 
assessment of the number of medication discrepancies (Hron et al., 2015; Huynh et al., 2013; 
Huynh et al., 2016; Stock et al., 2009; Varkey et al., 2007; Weingart et al., 2007). Although, the 
evidence by Nassaralla et al. (2007) and Nassaralla et al. (2009) used different terminology 
(completeness, correctness, and accuracy) the idea of monitoring the number of discrepancies 
was still present. Another common theme in the literature related to the number of medication 
discrepancies was the assignment of severity (Hron et al., 2015; Huynh et al., 2013; Huynh et 
al., 2016; Varkey et al., 2007). Classifying the severity was in an effort to assess the possible 
adverse outcome had the discrepancy not been identified.  
In addition to there being common measurable outcomes, there were common 
interventions mentioned. In three of the four adult outpatient studies, the intervention had two 
components: a patient component and a provider component (Nassaralla et al., 2007; 
Nassaralla et al., 2009; Varkey et al., 2007). The patient component generally consisted of: (a) a 
reminder to bring their medications to the visit, (b) a brochure or letter emphasizing the 
importance of medication safety and reconciliation, and (c) education about the Med Rec 
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process. The provider component generally consisted of: (a) education regarding the 
importance of the Med Rec process, (b) specific role assignment in the process, and (c) 
individual updates of Med Rec compliance and accuracy (Nassaralla et al., 2007; Nassaralla et 
al., 2009; Varkey et al., 2007). The one source that focused on both the pediatric and adult 
outpatient population had a similar intervention (Weingart et al., 2007). 
 Many healthcare organizations, in both the inpatient and outpatient setting, are seeking 
ways to implement best practice and ensure patient medication safety. From the literature, one 
realizes that Med Rec has a large impact on medication safety. With the improvement of an 
existing Med Rec process, medication safety can improve. Clear delineation of the Med Rec 
process is the first goal in providing evidence-based care. Measuring and monitoring the 
number of medication discrepancies will give the team members a sense of whether the Med 
Rec process intervention is, in fact, meeting goals. The severity of the discrepancies sheds light 
into the potential ADE’s that occurred or could have occurred. Finally, an intervention that 
includes both patients and healthcare providers is supported and recommended repeatedly in 
the literature. 
Best Practice Model Recommendation 
After appraisal and synthesis of the current literature, the importance of not only 
measuring medication discrepancies, but preventing them became clear. The literature guided 
the PL to the overall outcomes to be measured and intervention themes. Although, the reviewed 
studies were not conducted in both the correct setting and population, the information and 
recommendations can be tailored to the pediatric hematology/oncology outpatient population. 
The outcome chosen for this EBP project, measurement of medication discrepancies and their 
severity, was commonly used in the evidence. The intervention chosen for this EBP project was 
based on the adult outpatient settings. These studies had current Med Rec processes in place, 
as did the project site, and the process was more similar to the project site than the pediatric 
inpatient evidence. The intervention was both patient and team member focused. It was 
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anticipated that implementing an intervention, which involved a standardized process, and 
patient and team member education would decrease the number and severity of medication 
discrepancies. Also, a decrease in the number of medication errors reported was anticipated.  
 The Kotter Model of Change was useful in implementing the change, or intervention. The 
model was helpful in laying the foundation and framework, in a setting in which change was 
greatly resisted. Kotter’s Model of Change emphasizes all team members working together to 
better the clinical environment, this is similar to the literatures emphasis on the multidisciplinary 
approach to Med Rec and the positive impact and role patients play in the process. The Stetler 
EBP Model was appropriate in aiding the implementation of evidence into clinical practice, with 
the goal of improving care provided to patients. 
 In order to assess the current climate and belief regarding the Med Rec process, a 
survey was conducted prior to implementation of the intervention and at the conclusion of the 
EBP project. The survey was designed by the PL and completed by team members. Baseline 
data from the EHR was collected by the physicians and PL. The number, type, and severity of 
the medication discrepancies and the number of reported medication errors was collected. 
These data were then collected again after the intervention took place. The definitions of 
completeness, correctness, and accuracy found in the literature (Nassaralla et al., 2007; 
Nassaralla et al., 2009) were used to evaluate individual medications and the overall medication 
list. The severity of the discrepancies was measured using the class 1, 2, and 3 scale (Huynh et 
al., 2013; Huynh et al., 2016). The outcomes would have ideally been collected using the EHR; 
however, this was not be possible. Collecting the data from the EHR was not possible because 
the EHR did not provide the ability to see who made changes to the medication list, what 
changes were made, and when the changes were made. Discussions with the IT department 
were helpful in answering this question. Therefore, the data were collected by the physicians at 
the project site, who conducted the last step in the Med Rec process, and also by the PL. The 
PL was responsible for educating the physicians on appropriate data collection technique. The 
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medication error information was collected using the sites computer system, where medication 
errors are voluntarily reported. 
 The literature, conducted in the adult outpatient setting, was the basis for the proposed 
intervention (Nassaralla et al., 2007; Nassaralla et al., 2009; Varkey et al., 2007; Weingart et al., 
2007). The project intervention included two components: a patient component and a team 
member component. The patient component consisted of a verbal call reminder to bring 
medications during the visit. This reminder was given by the unit assistants who makes the 
reminder phone calls. Also, a handout, created by the PL, emphasizing the importance of 
medication safety and reconciliation was provided to the patients during their office visit. Patient 
education regarding their role in the Med Rec process and their intricate involvement in Med 
Rec was reviewed by the MA or nurse, during their visit. At the project site, the team member 
component included unit assistants, MAs, and registered nurses. The team member component 
included education regarding the importance of the Med Rec process and the specific role 
assignment in the process. Also, updates regarding the Med Rec completeness, correctness, 
and accuracy were distributed to team members during the post-intervention phase, via email. 
How the Best Practice Model will Answer the Clinical Question 
 The reviewed and synthesized literature offered an answer to the clinical question: Will a 
standardized, collaborative Med Rec process that is communicated to all team members and 
patients decrease the number of medication discrepancies? The implementation of the evidence 
based intervention was guided by the Kotter Model of Change and the Stetler EBP Model. To 
assess the impact of the proposed intervention, the number, type, and severity of medication 
discrepancies and the total number of medication errors reported was examined. The results of 
this project determined if the intervention, both patient and team member, reduced the number, 
type, and severity of medication discrepancies and medication errors. It was hoped that a 
reduction in medication discrepancies would ultimately improve patient medication safety, in a 
pediatric outpatient hematology/oncology clinic.  
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CHAPTER 3 
IMPLEMENTATION OF PRACTICE CHANGE  
After identification of a clinical problem and synthesis of the literature, planning 
implementation of a practice change was of utmost importance. As discussed previously, in 
Stetler’s EBP Model the first three stages lead up to the fourth stage: application/translation. 
Stetler’s Model emphasized the importance of planning prior to implementing the best evidence 
based practice. The ultimate goal of implementing this EBP project was to improve pediatric 
hematology/oncology medication safety, by implementing the best Med Rec process.  
In order to protect participants and ensure their ethical treatment, IRB approval from 
both Valparaiso University and the clinical agency was obtained. Throughout the EBP project 
time frame, the PL monitored the practice change. The PL monitored the Med Rec process and 
also ensured participant safety and confidentiality were maintained. Chapter 3 details the 
methods that were used to implement this EBP project. The specific items discussed include: 
participants and setting, outcomes, intervention, planning, data, and protection of human 
subjects.  
Participants and Setting 
This EBP project took place in a pediatric hematology/oncology outpatient clinic in the 
Midwest. The pediatric hematology/oncology outpatient clinic provides services Monday through 
Friday and offers access an on-call physician 24 hours a day, seven days a week. The clinic, on 
average, has 2,500 patient visits per year. The Med Rec process occurs at every patient visit in 
which a physician evaluates the patient. The process spans from the patient’s arrival to the 
clinic, to the conclusion of the visit. The patient and the following team members are included in 
the Med Rec process: unit assistants, MAs, registered nurses, and physicians. The goal was to 
standardize the Med Rec process and improve Med Rec accuracy. The improvement in 
accuracy required a combined effort, from all patients and all team members. It was the PL’s 
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hope that all team members would be available for the team component of the intervention and 
would be included in the Med Rec process improvement. However, the physicians were not 
present for the team member component of the intervention. The lead physician was educated 
by the PL regarding the change in process and then the lead physician educated the other 
physicians. It was also the PL’s hope that all patients would realize the benefit of their 
involvement in the Med Rec process.  
Outcomes 
 There were several outcomes assessed during the project implementation. In order to 
assess the current climate and beliefs regarding the Med Rec process, a survey was conducted 
prior to implementation of the intervention. A survey was also used to assess the climate and 
beliefs regarding the Med Rec process at the conclusion of the project (see Appendices A and 
B). The surveys were designed by the PL.  
Baseline data from the EHR were collected to examine the number, type, and severity of 
medication discrepancies. These baseline data collections occurred for three weeks prior to the 
intervention and were collected by both the physician and the PL. The number, type, and 
severity of medication discrepancies were collected again by the physicians and the PL after the 
intervention took place (see Appendices C and D). The definitions of completeness, 
correctness, and accuracy found in the literature (Nassaralla et al., 2007; Nassaralla et al., 
2009) were used to evaluate individual medications and the overall medication list. In order for 
the PL to collect correctness data the patients/caregivers were contacted via telephone to 
assess whether what was documented in the EHR was in fact what the patient was taking at 
home. Correctness data were collected on half of the patients the physicians collected 
medication discrepancy data on. Random sampling was used to select the patients. The 
severity of the discrepancies were measured using the class 1, 2, and 3 scale found in the 
literature. Class 1 was defined as a potentially minor error. Class 2 was defined as a potentially 
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moderate error. Class 3 was defined as a potentially severe error (Huynh et al., 2013; Huynh et 
al., 2016). 
Finally, the number of voluntarily reported medication errors was assessed. The 
medication error reports were collected from the computer incident report system. The number 
of reports pre and post-intervention were compared, as well as examination of the medication 
error reports, during the same time the previous year. 
Intervention 
The overall goal of this EBP project was to improve medication safety in a pediatric 
outpatient setting. This medication safety improvement was facilitated by enhancement of the 
Med Rec process. The intervention was based on synthesis of the literature. The intervention 
had two components: a patient/caregiver component and a team member component. The 
patient/caregiver component included three elements: (1) prompting caregivers during the visit 
reminder call to bring the patient’s medications to the visit, (2) a handout given to the patient 
during their visit that emphasized the patient’s role in the Med Rec process (see Appendix E), 
and (3) individual education regarding the Med Rec process during the patient’s visit.  
 The team member component included: (1) education regarding Med Rec, (2) 
development of a standardized Med Rec process, and (3) medication discrepancy feedback via 
email. Team members attended an educational meeting, in which a PowerPoint® was 
presented (see Appendix F). The information was presented during a monthly team member 
meeting. The PL introduced the project topic and details to the team members. The 
PowerPoint® included: background Med Rec information, data from the literature, project 
intervention information, and baseline data collected from the clinic. A short Med Rec 
informational handout was given to team members as a reminder (see Appendix G). The 
baseline data included the number, type, and severity of the medication discrepancies and the 
anonymous survey results. During this meeting, the current Med Rec process was reviewed. A 
new standardized process was outlined and agreed upon by all team members. 
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Planning 
There were two phases of this EBP project. The first phase consisted of baseline data 
collection, prior to the intervention. During Phase 1, the pre-intervention survey was distributed 
and completed by team members (see Appendix A). Also, pre-intervention data were collected. 
This data included the number of medication discrepancies. The discrepancies were classified 
by type and severity. The physicians collected completeness, correctness, and accuracy data 
from the EHR. The PL collected demographic, completeness, correctness, and accuracy data 
from the EHR and telephone conversation. Data from the Physician Medication Reconciliation 
Tracking Form was coded by the PL, in an effort to promote patient information protection (see 
Appendix H). Phase 1 data collection lasted three weeks. One and half weeks were allowed to 
analyze the data and add the data to the educational PowerPoint®.  
 Phase 2 began immediately following the intervention. The intervention began with the 
educational meeting, facilitated by the PL. During Phase 2, the team members completed a data 
collection form on all patients (see Appendix I). This form served as a reminder and a means to 
monitor key components of the Med Rec process. Phase 2 data were collected for three weeks. 
Similar to Phase 1, data included the number of medication discrepancies. The discrepancies 
were further classified by type and severity. Phase 2 data were collected by the clinic team 
members, physicians, and PL. The PL was frequently available to educate and encourage 
process compliance. At the half way mark of Phase 2, an email was sent from the PL to the 
team members detailing the overall number, type, and severity of the medication discrepancies 
found by the physicians and PL. The email also included words of encouragement and 
acknowledgement of the difficulty of change. This email update was in an effort to improve team 
member involvement and the consistent use of the standardized process.  
At the completion of Phase 2, a post-intervention survey, designed by the PL, was 
completed by all team members (see Appendix B). This was in an effort to assess team 
member’s perception of the revised Med Rec process. Also, at the end of Phase 2, the PL 
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collected the voluntary medication error reports that were completed during the length of the 
project. The length of Phase 1 and 2 combined was eight weeks. 
Data 
The survey, used during Phase 1 and Phase 2, collected minimal demographic data 
from the team members, including age, race, gender, level of education, current employment 
status, and years of practice in the project setting (see Appendices A and B). The survey 
assessed the team member’s beliefs surrounding the efficiency and accuracy of the current Med 
Rec process. Based on the results of the survey, a collaborative effort was made to standardize 
the Med Rec process. The standardized process included role delegation for each process step.  
 During Phase 2, team members were required to complete a form tracking the important 
components of the standardized Med Rec process (see Appendix I). This form served as a 
reminder to team members of the new standardized Med Rec process.   
During Phase 1 and 2 the number, type, and severity of the medication discrepancies 
were collected by the physicians and the PL. Medication discrepancy included completeness, 
correctness, and accuracy. A medication in the EHR was considered complete if the name, 
dose, frequency, and route of administration were specified. A medication was considered 
correct if there were no discrepancies between the medication list in the EHR and the 
medications the patient was taking at home. Medication discrepancy data were collected by the 
physicians on the patients seen in the clinic. The PL also verified the patient medication list 
using the EHR and calling the patient to verify correctness. Half of the patients that the 
physicians collected discrepancy data on were called in an effort to collect correctness data. 
The data collection forms used by the physicians and the PL were coded to ensure patient 
confidentiality (see Appendices C and D).  
 Finally, the PL assessed the number of medication errors reported during duration of the 
project. The medication error reports completed during the project time were compared to the 
same time frame the year before.  
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Measures 
 The reliability and validity of the data measures used in an EBP project are important to 
discuss. Measures are considered reliable when consistent measurements are obtained over 
time (Dougherty, 2015). Validity addresses whether the measurement measures what it is 
supposed to measure (Brewer & Alexandrov, 2015). Internal and external validity are two types 
of validity. Internal validity can be defined as “the degree to which it can be inferred that the 
experimental intervention (independent variable), rather than uncontrolled, extraneous factors, 
is responsible for observed effects” (Polit & Beck, 2012, p. 731). External validity can be defined 
as “the degree to which study results can be generalized to setting or sample other than the one 
studied” (Polit & Beck, 2012, p. 727).  
 The outcomes that were measured in this EBP project have been used in many studies, 
examining the accuracy of Med Rec. These outcomes were selected by the PL in an effort to 
obtain similar information as past studies supporting internal validity. The same process was 
used to collect the number, type, and severity of medication discrepancies, in both Phase 1 and 
Phase 2. The data collection was done by one person, the PL, in order to support reliability. 
 EHR data and telephone calling were chosen as the data sources, opposed to the PL 
directly observing the completion of the Med Rec process. The use of EHR data were in an 
effort to decrease the impact that the presence of the PL might have had on the process. This 
increased the reliability and validity of the data collection.  
Collection 
All data were collected and organized by the PL. The surveys completed by team 
members, both at the beginning of Phase 1 and at the completion of Phase 2, were anonymous. 
Team members were instructed to place the completed survey in a locked box at the nurse’s 
station, in the pediatric hematology/oncology outpatient clinic. Surveys were reviewed for 
commonalities. Themes from Phase 1 surveys were presented, anonymously, in the 
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PowerPoint®, during the team member meeting (see Appendix F). This was in an effort to 
analyze the current Med Rec process and formulate an improved standardized process. 
A portion of Phase 1 data, or pre-intervention data, was collected by the PL from the 
patients EHR. All electronic data were accessed using a password protected account. The data 
were coded to ensure patient privacy (see Appendix H). Coded data were kept separately from 
data containing patient information, both in locked boxes.  
 In Phase 2, the data collection form completed by the team members was collected in a 
locked box, located at the nurse’s station in the clinic (see Appendix I). The data collection 
forms were collected, by the PL, from the box once a week. The forms were then placed in an 
envelope for transport to a work station on the unit, in an effort to keep patient information 
confidential. The forms were coded and patient labels were removed at this time (see Appendix 
H). The coded data were kept separately from the code sheet, both in locked boxes. Similar to 
Phase 1, the EHR was accessed to collect demographics and medication discrepancy data, 
using a password protected account. Study data will be destroyed at the conclusion of the EBP 
project and after dissemination of the project results.   
Management and Analysis 
 Data collected during the project was analyzed by the PL using Statistical Package for 
the Social Sciences (SPSS) 22, a computer program for statistical analysis. Phase 1 and 2 data, 
specifically the number, type, and severity of the medication discrepancies, were compared 
using descriptive statistics. The mean and standard deviation of the number of discrepancies 
was examined. An update on the number, type, and severity of medication discrepancies was 
sent to team members, via email. The overall trends in medication discrepancies were 
analyzed. Retrospectively, the number of medication error reports was examined. The number 
of reports during Phase 1 and 2 were compared, as well as examination of the medication error 
reports, during the same time the previous year. 
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Protection of Human Subjects 
Prior to planning and implementing this EBP project, the PL completed a web based 
ethics training, through the National Institute of Health (see Appendix J). This training certified 
the PL to uphold ethical consideration, during the entirety of this EBP project. Approval from 
both Valparaiso University’s and the agency’s IRB was received. Once approval was obtained, 
the PL contacted the project site’s contact person and set up a calendar for project 
implementation.  
 The surveys completed at the end of Phase 1 and 2 were anonymous, to protect team 
member’s privacy. Completed surveys were placed in a locked box at the nurse’s station, prior 
to collection. The Physician Medication Reconciliation Tracking Form and the Medication 
Reconciliation Process Data Collection Form both included patient identification information at 
the top (see Appendices C and I). These forms were completed by team members, and upon 
completion, were placed in a locked box. The collected forms were collected and coded by the 
PL. Once the forms were coded the patient identification information was removed from the 
form, to protect patient information. Coded data were kept separate from the master code sheet, 
both in locked boxes. All data collection materials will be destroyed after project conclusion and 
results dissemination. 
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CHAPTER 4 
FINDINGS 
The purpose of this EBP project was to improve the accuracy of the Med Rec process in 
a pediatric hematology/oncology outpatient clinic by developing, promoting, and evaluating a 
standardized, collaborative Med Rec process. A detailed literature search was conducted in an 
effort to implement an evidence-based intervention that would improve outcomes. The clinical 
question this EBP project addressed was: Will a standardized, collaborative Med Rec process 
that is communicated to all team members and patients, decrease the number of medication 
discrepancies? The evidence-based intervention included a patient/caregiver component and a 
team member component. The outcomes measured during Phase 1 and 2 included the number, 
type, and severity of medication discrepancies and the number of medication errors reported via 
a voluntary computer system. Also, a survey assessing the climate of the Med Rec process was 
completed by team members and collected by the PL during Phase 1 and 2. Data were 
collected during Phase 2 that assessed the implemented Med Rec process compliance. 
Participant characteristics and descriptive statistics were calculated using SPSS 22. 
Participants 
 The participant analysis is comprised of the team members who completed the Phase 1 
and 2 survey and patients seen in the clinic during Phase 1 and 2. During both Phase 1 and 2, 
the number of visits, or number of Med Rec process completions, was recorded because one 
patient could have presented for numerous visits. The number of medications the patient was 
taking including OTC, herbal supplements, vitamins, and prescriptions was recorded for each 
visit as well. The sample size and characteristics will be further discussed at this time. 
Size 
 Demographic data were collected on team members who completed a survey, both prior 
to the completion of Phase 1 and 2. A total of nine team members completed the survey at the 
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conclusion of Phase 1 and a total of five team members completed the survey at the conclusion 
of Phase 2. Demographic survey data collected included age, gender, ethnicity, highest level of 
education, current employment status, current position, and length of employment in the project 
setting. Med Rec accuracy information was collected during Phase 1 and 2 by both the 
physicians and PL. Demographic data were collected by the PL on patients during Phase 1 (n = 
78) and Phase 2 (n = 94). There were 172 patient participants in this EBP project. Patient 
demographic data collected included age, gender, and diagnosis. Diagnosis was divided into 
two categories, oncology related or hematology related. During the duration of the project, both 
Phase 1 and 2, there were 229 visits in which the Med Rec process was completed and 
reviewed by the physician. Phase 1 included 99 visits and Phase 2 included 130 visits. Half of 
the visits during Phase 1 (n = 50) and Phase 2 (n = 65) were randomly selected by the PL for 
PL Med Rec accuracy data collection.  
Characteristics 
 Team members. The average age of team members during Phase 1 was 49.4 years 
(SD = 10.4) with a range of 33-63 years. All team members that completed the Phase 1 survey 
were female and Caucasian. Two team members (22.2%) reported their highest level of 
education being some college, three (33.3%) reported having an associate’s degree, three 
(33.3%) reported having a bachelor’s degree, and one (11.1%) participant reported having a 
medical degree. Employment status varied from full-time (n = 7, 77.8%), part-time (n = 1, 
11.1%), to as needed (n = 1, 11.1%). One physician (11.1%), six nurses (66.7%), and two unit 
assistants (22.2%) completed the Phase 1 survey. The average length of team member 
employment at the clinical site was 12.2 years (SD = 10.0) with a range of 1.5-24 years. 
The average age of team members during Phase 2 was 53.4 years (SD = 11.9), with a 
range of 33-63 years. All team members that completed the Phase 2 survey were female and 
Caucasian. Highest level of education included: one team member (20%) reported some 
college, three (60%) reported having an associate’s degree, and one (20%) reported having a 
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bachelor’s degree. All team members who completed the Phase 2 survey reported working full-
time. Four nurses (80%) and one unit assistant (20%) completed the Phase 2 survey. The 
average team member length of employment at the clinical site was 16.9 years (SD = 10.5) with 
a range of 1.5-24 years.        
There was no significant difference in team member age between Phase 1 and 2 (t(14) = 
-.644, df = 11, p = .533). There was no significant difference in team member’s highest level of 
education between Phase 1 and 2 (X2 = 1.296, df = 3, p = .730). There was no significant 
difference in team member’s employment status between Phase 1 and 2 (X2 = 1.296, df = 2, p = 
.523). There was no significant difference in employee’s position between Phase 1 and 2 (X2 = 
0.643, df = 3, p = .725). There was no significant difference in team members age between 
Phase 1 and 2 (t(14)= -.772, df = 11, p = .456).  
 Patients. In Phase 1, the average age of patients (n = 78) was 9.4 years (SD = 6.0). In 
Phase 1, 32 (41%) patients were female and 46 (59%) were male. Fifty patients (64.1%) had 
oncology related diagnoses and 28 patients (35.9%) had hematology related diagnoses. 
In Phase 2 the average age of patients (n = 94) was 9.6 years (SD = 6.2). In Phase 2, 39 
(41.5%) patients were female and 55 (58.5%) were male. Sixty two patients (66%) had oncology 
related diagnoses and 32 patients (34%) had hematology related diagnoses.  
There was no significant difference in age between Phase 1 and 2 patients (t(172) = -
.220, df = 170, p = .826). There was no significant difference in gender between Phase 1 and 2 
patients (X2 = .004, df = 1, p = .951). There was no significant difference in diagnosis between 
Phase 1 and 2 patients (X2 = .065, df = 1, p = .799). 
 Visits. The average number of medications reconciled per visit during Phase 1 (n = 99) 
was 4.9 medications (SD = 3.6), with a range of 0-13 medications. The average number of 
medications reconciled per visit during Phase 2 (n = 130) was 4.8 medications (SD = 3.8), with 
a range of 0-14 medications. There was no significant difference in the number of medications 
reconciled during Phase 1 and 2 patient visits (t(229) = .163, df = 227, p = .871).  
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 When considering only the patient visits reviewed by both the physician and the PL, the 
average number of medications reconciled per visit during Phase 1 (n = 50) was 5.1 
medications (SD = 3.7), with a range of 1-13 medications. The average number of medications 
reconciled per visit during Phase 2 (n = 65) was 4.8 medications (SD = 3.8), with a range of 0-
14 medications. There was no significant difference in the number of medications reconciled 
during Phase 1 and Phase 2 patient visits (t(115) = .431, df = 113, p = .680). 
Changes in Outcomes 
Reliability 
 For this EBP project, the PL created the data collection tools. The data collection tools 
included the Phase 1 and 2 team member survey, the Med Rec tracking forms, and the Med 
Rec process data collection form. Internal consistency testing, using Cronbach alpha, was not 
appropriate, although steps were taken to ensure reliability. The data collected was nominal and 
single items were used to measure distinct concepts. The team members responsible for data 
collection were educated on proper data recording technique. In an effort to ensure reliability, 
the physician’s and PL used the same data collection forms during Phase 1 and Phase 2 and 
used the same recording process during each phase. 
Statistical Testing and Significance 
 Primary outcomes. Primary outcomes of this EBP project include the number, type, 
and severity of medication discrepancies. Medication discrepancies were defined using the 
terms completeness, correctness, and accuracy found in the literature (Nassaralla et al., 2007; 
Nassaralla et al., 2009). A medication list was considered complete when each medication had 
a name, dose, frequency, and route of administration documented in the EHR. A medication list 
was considered correct if there were no discrepancies between the medication list in the EHR 
and what medications the patient was taking at home. Med Rec accuracy was defined as a 
medication list being both complete and correct. When a medication discrepancy was found its 
severity was classified. The severity of the discrepancies were classified using the class 1, 2, 
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and 3 scale (Huynh et al., 2013; Huynh et al., 2016). Class 1 was assigned to medication 
discrepancies that were potentially minor. Class 2 was assigned to medication discrepancies 
that were potentially moderate. Class 3 was assigned to medication discrepancies that were 
potentially severe. Medication discrepancy data was collected by both the physician and the PL. 
Also, the number of voluntarily reported medication errors was assessed during the duration of 
the project and the same time frame the previous year. 
Med Rec Discrepancies. The physicians collected Med Rec data on 229 patient visits, 
Phase 1 (n = 99) and 2 (n = 130). The PL then randomly selected half of the patients to verify 
Med Rec data on. An attempt was made to contact the randomly selected patients/caregivers 
via telephone to verify the correctness of the medication list documented in the EHR. During 
Phase 1, the PL attempted to complete correctness data on 50 patient visits. The Med Rec 
correctness was verified for 26 of the 50 patient visits (52%). In Phase 2, the PL attempted to 
complete correctness data on 65 patient visits. The Med Rec correctness was verified for 40 of 
the 65 patient visits (61.5%). There was no significant difference in the Med Rec correctness 
verification by the PL between Phase 1 and 2 (X2 = 1.051, df = 1, p = .305). There were three 
reasons correctness was not verified: the caregiver did not answer the telephone call, the 
caregiver refused to verify the patient’s medications with the PL, or the patient was admitted to 
the hospital. Figure 4.1 provides participant and non-participant information, specifically 
correctness verification information.  
 Accuracy. Accuracy data included whether the Med Rec was complete and correct. In 
Phase 1 the physician collected these data on 99 patient visits. The physician’s collected data 
from only the EHR. The Med Rec was recorded as accurate in 79 of the 99 (79.8%) patient 
visits. During Phase 2, Med Rec was recorded as accurate in 115 of the 130 (88.5%) patient 
visits. A chi-square test of independence was calculated comparing the results of all of the 
physician reported Med Rec accuracy during Phase 1 (n = 99) and 2 (n = 130). While the 
accuracy rate improved, no significant relationship was found (X2 = 3.258, df = 1, p = .071).  
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Figure 4.1 Phase 1 and Phase 2 Participant and Non-Participant Flow Chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
_________________ 
 
The PL randomly selected half of the patient visits that the physicians collected accuracy 
data for Phase 1 and 2. The PL data were collected from both the EHR and the caregiver (via 
telephone call). During Phase 1, 19 (73.1%) of the 26 verified Med Recs were found to be 
accurate. In Phase 2, 29 (72.5 %) of the 40 verified Med Reds were found to be accurate. 
Overall, there was a slight decrease in the percentage of accurate Med Recs from Phase 1 to 
Phase 2 from 73.1% to 72.5%. A chi-square test of independence was calculated comparing the 
results of the PL reported Med Rec accuracy during Phase 1 and 2. No significant relationship 
was found (X2 = .003, df = 1, p = .959). 
Total Participants 
Phase 1: n = 99 
Phase 2: n = 130 
Randomly Selected 
Participants 
Phase 1: n = 50 (50%) 
Phase 2: n = 65 (50%) 
Correctness Participants 
Phase 1: n = 26 (52%) 
Phase 2: n = 40 (61.5%) 
Non-participants 
Phase 1: n = 24 (48%) 
Phase 2: n = 25 (38.5%) 
Admitted 
Phase 1: n = 2 (8.3%) 
Phase 2: n = 0 (0%) 
Refused 
Phase 1: n = 3 (12.5%) 
Phase 2: n = 2 (8%) 
Unreachable 
Phase 1: n = 19 (79.2%) 
Phase 2: n = 23 (92%) 
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When examining the patient visits in which the physician and PL both collected data, 
Phase 1 (n = 50) and Phase 2 (n = 65), there was a significant decrease in the number of 
inaccurate Med Recs recorded by the physicians (X2 = 8.167, df = 1, p = .004). In Phase 1, 35 
of 50 (70%) Med Recs were reported accurate and in Phase 2 59 of 65 (90.8%) were reported 
as accurate by the physicians (Figure 4.2). 
Figure 4.2 Inaccurate Med Recs 
 
Inaccuracy. The reason for Med Rec inaccuracy was recorded by both the physician 
and the PL. The Med Rec was considered inaccurate because it was incomplete, incorrect, or 
both. Incompleteness was defined as at least one medication missing the name, dose, 
frequency, or route of administration in the EHR. Incorrectness occurred when a discrepancy 
existed between the patient’s medication list in EHR and what medication(s) the patient was 
taking at home. In Phase 1 (n = 99) the physicians recorded, three (15%) of the 20 inaccurate 
Med Recs were incomplete, 16 (80%) were incorrect, and one (5%) was both incomplete and 
incorrect. In Phase 2 (n = 130), two (13.3%) of the 15 inaccurate Med Recs were recorded as 
incomplete, 13 (86.7%) were recorded as incorrect, and none were recorded as both incomplete 
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and incorrect. There was no significant difference between the physician reported Med Rec 
inaccuracy reason between Phase 1 and 2 (X2 = .813, df = 2, p = .666). 
In Phase 1 (n = 50) the PL recorded, five (71.4%) of the seven inaccurate Med Recs 
were incomplete, one (14.3%) was incorrect, and one (14.3%) was both incomplete and 
incorrect. In Phase 2 (n = 65), nine (81.8%) of the 11 inaccurate Med Recs were recorded as 
incomplete, two (18.2%) were recorded as incorrect, and none were recorded as both 
incomplete and incorrect. There was no significant difference between the PL reported Med Rec 
inaccuracy reason between Phase 1 and 2 (X2 = 1.670, df = 2, p = .434). 
When examining inaccurate Med Recs in which the physician and PL both collected 
data, in Phase 1 (n = 50) the physicians recorded, three (20%) of the 15 inaccurate Med Recs 
were incomplete, 11 (73.3%) were incorrect, and one (6.7%) was both incomplete and incorrect. 
In Phase 2 (n = 65), one (16.7%) of the six inaccurate Med Recs were recorded as incomplete, 
five (83.3%) were recorded as incorrect, and none were recorded as both incomplete and 
incorrect. There was no significant difference between the physician reported Med Rec 
inaccuracy reason between Phase 1 and 2 (X2 = .481, df = 1, p = .786). 
 Incompleteness. The reason for incomplete Med Recs was further delineated into what 
element of the medication was missing, specifically the name, dose, frequency, route of 
administration, or a combination (see Table 4.1). The incomplete combination noted in Phase 1 
was missing frequency and route. There was a significant difference between physician 
incompleteness data between Phase 1 and 2 (X2 = 6.000, df = 2, p = .050). The PL incomplete 
combinations in Phase 1 were two missing route and frequency, two missing dose and 
frequency, and one missing dose, frequency, and route. There was no significant difference 
between PL incompleteness data between Phase 1 and 2 (X2 = 5.278, df = 4, p = .260). When 
examining inaccurate Med Recs in which the physician and PL both collected data, there was 
no significant difference between physician incompleteness data between Phase 1 and 2 (X2 = 
5.000, df = 2, p = .082). 
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Table 4.1 
Incompleteness Data for Phase 1 and Phase 2 
 Total 
Physician 
Phase 1 
(n = 99) 
Total 
Physician 
Phase 2 
(n = 130) 
Matched 
Physician 
Phase 1 
(n = 50) 
Matched 
Physician 
Phase 2 
(n = 65) 
PL 
Phase 1 
(n = 50) 
PL 
Phase 2 
(n = 65) 
 
Total 
Incomplete 
 
Reason (# (%)) 
 
4 2 4 1 6 9  
  Name 
 
- - - - - - 
  Dose 
 
        - 2 (100) - 1 (100) 2 (33.3)  2 (22.2) 
  Frequency 
 
3 (75) - 3 (75) - 4 (66.7)  2 (22.2)   
  Route 
 
- - - - - - 
  Combination 1 (25) - 1 (25) - -  5 (55.6) 
Note. Combination includes medications missing more than one component, for example both 
dose and frequency missing. 
 
 Incorrectness. The reason for incorrect Med Recs were further delineated into what 
element of the EHR did not match what the patient was taking at home. Incorrectness options 
included addition, omission, duplication, incorrect name, incorrect dose, incorrect frequency, 
incorrect route of administration, or a combination (see Table 4.2). The incorrect combinations 
in Phase 1 included a medication list with an addition and an incorrect name documented. 
Phase 2 incorrectness combinations included a medication list with and addition and incorrect 
dose. There was no significant difference between physician incorrectness data between Phase 
1 and 2 (X2 = 7.014, df = 5, p = .220). 
 The PL recorded incorrectness combination in Phase 1 was a medication list that 
included an addition, omission, and incorrect dose. There was no significant difference between 
PL incorrectness data between Phase 1 and 2 (X2 = 2.000, df = 2, p = .368). 
 When examining inaccurate Med Recs in which the physician and PL both collected 
data, in Phase 1 the incorrect combination was the result of an addition and incorrect name. 
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There was no significant difference between physician incorrectness data between Phase 1 and 
2 (X2 = 1.747, df = 4, p = .782). 
Table 4.2 
Incorrectness Data for Phase 1 and Phase 2 
 Total 
Physician 
Phase 1 
(n = 99) 
Total 
Physician 
Phase 2 
(n = 130) 
Matched 
Physician 
Phase 1 
(n = 50) 
Matched 
Physician 
Phase 2 
(n = 65) 
PL 
Phase 1 
(n = 50) 
PL 
Phase 2 
(n = 65) 
 
Total Incorrect 
 
Reason (# (%)) 
 
       17 13 12 5 2 2  
Addition 
 
   3 (17.6) 2 (15.4) 1 (8.3) 1 (20)  - - 
Omission    8 (47.1) 10 (76.9) 8 (66.7)    4 (80) -         - 
 
Duplication 
 
- 
 
- 
 
         -    
 
- 
 
- 
    
1 (50) 
 
Incorrect name 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
Incorrect dose 
 
Incorrect 
  frequency 
 
Incorrect route 
 
Combination 
 
3 (17.6) 
 
2 (11.8) 
 
 
- 
 
1 (5.9) 
 
- 
 
- 
 
 
- 
 
1 (7.7) 
 
1 (8.3) 
 
1 (8.3) 
 
 
- 
 
1 (8.3) 
 
- 
 
- 
 
 
- 
 
- 
 
2 (50) 
 
- 
 
 
       - 
 
1 (50) 
 
       - 
 
     1 (50) 
 
 
        - 
 
        - 
Note. Combination includes and EHR medication list with one than one component not 
matching what the patient is taking at home, for example a patient with an omitted medication 
and a medication with an incorrect dose documented. 
 
 Severity. When the physicians or PL recorded a Med Rec as inaccurate, a severity was 
assigned. Class 1 was assigned to medication discrepancies deemed potentially minor. Class 2 
was assigned to medication discrepancies deemed potentially moderate. Class 3 was assigned 
to medication discrepancies deemed potentially severe. Figure 4.3 details total and matched 
physician and PL severity ratings for Phase 1 and 2. No inaccurate Med Recs were classified by 
the physicians or PL as severe in Phase 1 or 2. There was no significant difference in total 
physician Med Rec inaccuracy severity between Phase 1 and 2 (X2 = .034, df = 1, p = .854). 
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There was no significant difference in PL Med Rec inaccuracy severity between Phase 1 and 2 
(X2 = 1.039, df = 1, p = .308). When examining the matched physician inaccurate Med Rec 
severities there was no significant difference in Med Rec inaccuracy severity between Phase 1 
and 2 (X2 = .827, df = 1, p = .363).      
Figure 4.3 Inaccurate Med Rec Severity Ratings 
 
Note: No inaccurate Med Recs were given a class 3- severe rating by the physicians or PL. 
 
 Reported Medication Errors. There were no voluntary reported medication errors 
during the duration of this EBP project. There were no voluntary reported medication errors 
reported during the same time frame the previous year. 
 Secondary outcomes. Secondary outcomes of this EBP project included data collected 
by the team members regarding the compliance to the Med Rec process during Phase 2 and 
team member survey results prior to the end of Phase 1 and 2. The Med Rec process data 
collected included if the caregiver was reminded to bring the patients medication to the next 
visit, if the caregiver brought their child’s medications to the appointment, if the patient and 
caregiver were educated regarding the Med Rec process during the visit, if so by who (role), 
and if all three steps of the Med Rec process were completed (verification, clarification, and 
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reconciliation) and by who (role). Patient/caregiver education role options included the MA, 
nurse, or both the MA and the nurse. The Med Rec step completion role options included the 
MA, nurse, both the MA and the nurse, or the physician. Med Rec process data were collected 
on 111 (85%) of the 130 Phase 2 patient visits.  
 Medication reminder. The caregiver was reminded to bring their child’s medications to 
their child’s next visit prior to 91.9% (102 out of 111) of the patient visits during Phase 2. The 
main reason cited for not reminding caregivers to bring their child’s medications to the visit was 
lack of voicemail to leave a message or incorrect/disconnected phone number provided by 
caregiver (no statistical data available regarding reasons medication reminder did not occur). 
 Medications to appointment. Of the 130 patient visits in Phase 2, 106 had data 
recorded regarding whether the caregiver brought their child’s medications. For 55 (51.9%) of 
the patient visits, caregivers brought the child’s medication(s) to the appointment. For 32 
(30.2%) of the patient visits, caregivers did not bring their child’s medication(s) to the 
appointment. For 19 (17.9%) of the patients visits, children were recorded as not taking any 
medications, therefore none were brought to the appointment. 
 Patient education. First the team members indicated whether the patient/caregiver was 
educated. If the patient/caregiver was educated, the role of the educator was selected and could 
include MA, nurse, or both MA and the nurse. Already educated was also an option for the 
same patients with multiple visits. The team members recorded patient education data on 110 of 
the 130 patient visits in Phase 2. Sixty-eight (61.6%) of patients/caregivers were educated by 
the MA, 17 (15.5%) were educated by the nurse, and five (4.5%) were educated by both the MA 
and nurse. Twenty patients/caregivers (18.2%) were repeat patients and did not receive 
education the second time they presented for a visit. 
 Med Rec process. The Med Rec process section of the team member data form 
detailed if the steps of the Med Rec process (verification, clarification, and reconciliation) were 
completed and by who. Verification and clarification role completion options included MA, nurse, 
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or both the MA and nurse. The only reconciliation role option included was physician, as the 
physician was the only person responsible for the completion of the Med Rec process. Sixty-five 
percent (58 out of 89) of Med Rec verification was completed by the MA, 20% (18 out of 89) 
was completed by the nurse, and 15% (13 out of 89) was completed by both the MA and the 
nurse. Fifty-nine percent (51 out of 87) of Med Rec clarification was reported as completed by 
the MA, 28% (24 out of 87) was completed by the nurse, and 14% (12 out of 87) of the 
clarification was completed by both the MA and the nurse. One hundred percent (87 out of 87) 
Med Recs were reconciled by a physician. 
 Team member survey. The demographics collected from the team member survey 
were previously discussed. Common themes were present when the PL reviewed the open-
ended questions of the survey. At the conclusion of Phase 1, when asked what aspects of the 
Med Rec process were working well, team members commonly identified the use of the EHR, 
especially for repeat patients, as a tool in reducing time. When asked what aspects of the Med 
Rec process were not working well team members commonly discussed patients not bringing 
their medications to their visits and team members not thoroughly reviewing the medication list 
upon patient arrival. Future ideas for improvement commonly included reviewing medications in 
detail with all patients and nurses completing the Med Rec process with the help of the 
physician. 
 Phase 2 survey results also found common themes. All participants reported that the 
caregivers should continue to be reminded to bring their medications to their next visit, 
patients/caregivers should continue to be educated regarding Med Rec, and that the Med Rec 
process and discrepancies should continue to be tracked.      
Significance 
 There were no significant differences in patient age, gender, or diagnosis between 
Phase 1 (n = 50) and 2 (n = 65) (p < .799). No significant difference in the number of 
medications per visit between Phase 1 and 2 (t(229) = .163, df = 227, p = .871) was found. The 
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physician data for all patient visits reported an improvement in the Med Rec accuracy (X2 = 
3.258, df = 1, p = .071). Also, the matched physician patient visits exhibited a significant 
improvement in the number of inaccurate Med Recs between Phase 1 and 2 (X2 = 8.167, df = 1, 
p = .004). There was a slight increase in the number of inaccurate Med Recs the PL recorded 
between Phase 1 (26.9%) and 2 (27.5%) (X2 = .003, df = 1, p = .959). Physicians more 
commonly reported Med Recs were inaccurate related to incorrectness, whereas the PL 
reported more Med Recs were inaccurate related to incompleteness.  
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CHAPTER 5 
DISCUSSION 
 This EBP project explored the clinical question: Will a standardized, collaborative Med 
Rec process that is communicated to all team members and patients, decrease the number of 
medication discrepancies? The PICOT question developed was: In the pediatric 
hematology/oncology outpatient population, how will the implementation of a standardized, 
collaborative Med Rec process affect the number of medication discrepancies over the course 
of two months, when compared to the current Med Rec practice? The goal of this EBP project 
was to reduce the number of medication discrepancies and improve the current Med Rec 
process using current evidence found in the literature. The outcomes measured included the 
number, type, and severity of medication discrepancies and the number of medication errors 
reported via a voluntary computer system. Also, a survey assessing the climate of the Med Rec 
process was completed and Med Rec process compliance was tracked. This chapter discusses 
the EBP project findings, applicability of the theoretical and EBP frameworks, strengths and 
limitations of the project, and implications for the future. 
Explanation of Findings 
Primary outcomes of this EBP project included the number, type, and severity of 
medication discrepancies. Also, the number of voluntarily reported medication errors was 
assessed during the duration of the project and the same time frame the previous year. 
Secondary outcomes of this EBP project included data collected by the team members 
regarding compliance to the Med Rec process during Phase 2, and team member survey results 
prior to the end of Phase 1 and 2. 
Primary Outcomes 
The accuracy of the Med Rec process during both Phase 1 and 2 was compared using 
chi-square testing. When considering the overall physician Med Rec accuracy during Phase 1 
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and 2, there was an increase in the number of accurate Med Recs, although not significant (X2 = 
3.258, df = 1, p = .071). When considering the matched physician Med Rec accuracy data 
during Phase 1 and 2, there was a significant increase in the number of accurate Med Recs (X2 
= 8.167, df = 1, p = .004). The PL randomly selected half of the patient visits in which Med Rec 
accuracy, specifically the correctness, was verified. Overall, there was a slight decrease in the 
percentage of accurate Med Recs from Phase 1 to 2 and no significant relationship was found 
(X2 = .003, df = 1, p = .959). The PL was the only person responsible for completing the Med 
Rec accuracy data collection, in which the patient was called to verify data. Multiple physicians 
were responsible for Med Rec accuracy data, using the EHR and their personal knowledge of 
the patient’s plan of care. 
The physicians and PL considered the Med Rec inaccurate if it was incomplete, 
incorrect, or both. The physicians found a larger number of inaccurate Med Recs related to 
incorrectness, whereas the PL found a larger number of inaccurate Med Recs related to 
incompleteness. There was no significant difference between the physician or PL Med Rec 
inaccuracy reason between Phase 1 and 2 (p = .434). One explanation for the difference in 
correctness between the physician and PL’s accuracy is that the physicians may have reviewed 
the Med Rec, found the incorrectness, fixed the discrepancy, and then the PL verified the 
correct EHR list with the patient. Also, the PL may have completed a more detailed review of 
each component of the medication, specifically looking for documentation of each medications 
name, dose, frequency, and route of administration.  
Regardless of the Med Rec reviewer, the most commonly missed component of the 
medication documentation, causing inaccuracy, was a medication missing the frequency or 
dose. An example of an incomplete medication documentation related to missing frequency was 
Tylenol 650 mg PO prn pain. Another example of an incomplete medication documentation 
related to missing dose was Tylenol PO Q6H prn pain. Both examples represent an inaccurate 
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Med Rec. The PL found Med Recs that were recorded as accurate by physicians that were in 
fact not accurate as a result of incompleteness. 
The most commonly recorded incorrectness reason by the physicians was omission. It is 
interesting to note that the PL did not record any instances where the Med Rec was inaccurate 
related to a medication omission. Perhaps this could be attributed to the fact that the physicians 
are developing and implementing the plan of care. They could be considered the most 
knowledgeable person when it comes to knowing what medications the patient is currently 
taking. 
When the physicians or PL recorded a Med Rec as inaccurate, a severity was assigned. 
Regardless of the reviewer, the most commonly assigned severity was class 1, or minor, 
followed by class 2, or moderate. No inaccurate Med Recs were classified by the physicians or 
PL as severe in Phase 1 or 2. The severity rating was subjective and offered insight into the 
possible ramifications of the inaccurate Med Rec. 
 There were no voluntary reported medication errors during the duration of this EBP 
project. There were no voluntary reported medication errors reported during the same time 
frame the previous year. The team members were encouraged during the education component 
of the intervention to complete medication error reports when Med Recs were inaccurate and 
patient safety was compromised. 
Secondary Outcomes 
 Secondary outcomes of this EBP project included data collected by the team members 
regarding compliance to the Med Rec process during Phase 2 and team member survey results 
prior to the end of Phase 1 and 2. In regards to the Phase 2 Med Rec Process data collection, 
the caregiver was reminded to bring their child’s medications to the next visit prior to 91.9% of 
the patient visits. In Phase 2, the large percentage of completed patient/caregiver reminders 
may be due to the fact that the clinic had a system in place, prior to the implementation of this 
project, in which the caregivers were called and reminded of their child’s appointment. The 
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caregiver reminder to bring their child’s medications was not considered a time consuming task 
by many team members. Also, the unit assistants responsible for the reminder calls were 
receptive to improving the patient’s safety and encouraging caregiver involvement in the Med 
Rec process. The reasons cited for not reminding caregivers to bring their child’s medications to 
the visit, lack of voicemail to leave a message or incorrect/disconnected phone number provided 
by caregiver, were not something that could be controlled by team members in the clinic. 
Despite the large number of caregivers reminded to bring their child’s medications to the visit, a 
large percentage did not bring their child’s medications. Perhaps this is related to the frequency 
in which pediatric hematology/oncology patients are visiting the outpatient clinic. However, 
these data provide additional support to augment the process of reminding caregivers to bring 
medications to each child’s visit.  
 Overall, team members did an excellent job of educating the caregivers and patients, 
using the handout for Med Rec. All the patients with Med Rec process data collected were 
educated if it was their first visit. The majority of the education was performed by the MA. During 
the duration of the project, the MA was responsible for checking the patient in and performing 
the first two steps of the Med Rec process. This could be the reason why the patient/caregiver 
was most commonly educated by the MA. This could also be the reason that the first two steps 
of the Med Rec process were most commonly completed by the MA. The final Med Rec process 
step, reconciliation, was recorded as 100% completed by the physicians. It is important to 
mention that, after the project was completed, the Med Rec process changed and now the 
nurse is responsible for the Med Rec verification and clarification steps of the process. This 
change was in an effort further improve Med Rec accuracy and ensure that adequately trained 
team members were completing the Med Rec process. In this setting, the nurses have 
specialized training and certification in pediatric hematology/oncology care. 
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Relationship to the Current Literature 
 This EBP project confirmed literature findings that it is challenging to improve medication 
safety in pediatrics, using the Med Rec tool (Huynh et al., 2013). In this EBP project setting, the 
Med Rec inaccuracy rate reported by the physicians in Phase 1 was 20.2% and in Phase 2 the 
Med Rec inaccuracy rate reported by the physicians was 11.5%. Huynh et al. (2016) cited that 
58% of prescriptions contained a medication discrepancy. However, the Huynh et al. (2016) 
study was conducted in the pediatric inpatient setting and medication discrepancy was defined 
as a difference in the pre admission medication list and admission medication orders. This 
definition was not applicable to the pediatric outpatient setting in this project.  
Nassaralla et al. (2007) found improvement in correctness between pre- and post-
intervention was not significant (23.7% to 18%). Nassaralla et al. (2009) found that the overall 
number of complete medication lists improved between pre-intervention, LPN-intervention, and 
patient intervention phases. Also, the overall accuracy improved from pre-intervention (11.5%) 
to patient intervention (29%) (Nassaralla et al., 2009). These overall accuracy numbers, whether 
pre-intervention or post-intervention are lower than reported in this EBP project (Phase 1: 79.8% 
total physician accurate Med Recs and Phase 2: 88.5% total physician accurate Med Recs). In 
addition, Varkey et al. (2007) reported higher medication discrepancy numbers than reported in 
this project (Phase I: 98.2% Med Rec with a discrepancy and Phase II: 84% Med Recs with a 
discrepancy). When comparing the literature with the project site, there appears to be far less of 
a problem with inaccurate Med Recs. However, given the vulnerability of the patient population 
at the project site, Med Rec accuracy and patient safety can certainly be improved.  
 Varkey et al. (2007) found that incorrect or missing route was the most common 
medication discrepancy. This discrepancy is in contrast to this EBP project which found 
frequency to be the most commonly undocumented component of the Med Rec. Nassaralla et 
al. (2007) showed improvement in completeness, specifically the documentation of dose and 
route, between their pre-intervention, post-intervention, and sustainability phases. Again this is 
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in contrast to this project finding of missing frequency as the most common incompleteness 
reason.  
With regards to severity ratings, the physicians and PL reported no Med Rec 
inaccuracies as severe. This finding is in contrast to Huynh et al. (2016), in which the same 
classification system was used, when 22% of medication discrepancies were found to be class 
1 (minor), 50% were found to be class 2 (moderate), and 28% were found to be class 3 
(severe). The severity results of this project are similar to Hron et al. (2015) in which no major or 
catastrophic ADE’s were found pre-intervention or post- intervention. Finally, according to 
Varkey et al. (2007), the most commonly recorded severity was minor, 0.3% of medication 
discrepancies were serious and no lethal medication discrepancies were recorded.  
 When examining the percentage of visits in which medications were brought from home, 
a rate of 51.9% during Phase 2 of this project is more than the reported rate of 38.5% by Huynh 
et al. (2016) and the 13.9% pre-intervention and 33% post-intervention reported by Nassaralla 
et al. (2009). When compared with this project, Varkey et al. (2007) reported a similar number of 
visits with medications present in Phase II (52%). 
 Correctness during Phase 1 (52%) and Phase 2 (61.5%) of this EBP project was similar 
to what Nassaralla et al. (2007) reported, pre-intervention (69%) and post-intervention (61%). 
Also, Nassaralla et al. (2009) reported correctness participation similar to this EBP project, pre-
intervention (56%), LPN intervention (51%), and patient intervention (60%).  
 None of the literature used to formulate the intervention or data collection tools used a 
Med Rec process compliance tracking tool. The Med Rec process tracking tool was extremely 
helpful in this specific project setting. It served as a reminder to team members and increased 
individual accountability. 
Unexpected Findings 
 It was not anticipated that there would be a difference in the physician and PL reported 
number of accurate Med Recs. It was also not expected that there would be a slight increase in 
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the number of PL recorded inaccurate Med Recs between Phase 1 and Phase 2. The 
physicians found and corrected mostly incorrectness errors prior to the PL verifying the 
correctness. However, the physicians in both Phase 1 and Phase 2 did not find and report the 
incompleteness errors that the PL found. This could be related to the fact that the physicians are 
proficient and knowledgeable regarding the patient medication regimens, increasing the 
likelihood of finding incorrectness errors; however, the physicians could benefit from 
improvement in monitoring for incompleteness errors. The most frequently cited reasons for 
inaccuracies, specifically missing frequency for incompleteness and omission for incorrectness, 
were not expected based on the existing literature. The team member survey results prior to the 
conclusion of Phase 2 were surprising in that all participants expressed that the standardized, 
collaborative Med Rec process and tracking should continue. Finally, it was discovered that 
medication error reports are not commonly completed in this setting. This fact limited the ability 
to examine the effect of the implemented Med Rec process on patient safety. 
Evaluation of Applicability of Theoretical and EBP Frameworks 
 The theoretical framework that was used to guide this EBP project was Kotter’s Model of 
Change. In addition to Kotter’s Model of Change, the Stetler EBP Model was used to guide the 
implementation of best practice in the clinical setting. The theoretical framework and EBP 
framework appropriateness, strengths, and limitations are discussed further. 
Theoretical Framework 
Kotter’s Model of Change laid a foundation to successfully implement this EBP project 
and change current practice. The eight stages of Kotter’s Model of Change are: (1) establish a 
sense of urgency, (2) create a powerful guiding coalition, (3) develop a vision, (4) communicate 
the vision, (5) empower others to act on the vision, (6) plan for and create short-term wins, (7) 
consolidate improvements and produce more change, and (8) institutionalize new approaches 
(Ritter, 2011). Each stage of the model was used to overcome barriers to change in the project 
setting. 
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 Theoretical Framework Appropriateness. Kotter’s Model of Change was a good fit for 
the project, as it was detailed in its discussion of empowering team members to change current 
practice. This task was especially difficult in the project setting. The model set up an 
environment in which change was openly discussed and agreed upon. The baseline data 
collected were helpful in creating a sense of urgency and facilitating the realization of the clinical 
problem.  
Strengths of Theoretical Framework. Kotter’s Model of Change was useful when 
implementing this organizational change. Kotter’s Model of Change was easy to follow and 
simplistic, yet it was also thorough when it came to the entirety of the change process. The 
additional detail and steps that Kotter’s Model of Change offered, in comparison to Lewin’s 
Model of Change, was helpful to the novice PL. Also, the thoroughness was appreciated in a 
climate, such as the project site, where change was resisted and difficult to implement.  
Limitations of Theoretical Framework. Kotter’s Model of Change contains eight 
stages, which at times proved to be laborious and overwhelming to the novice PL. The model 
was described in a linear, step-by-step approach, which was more simplistic than change in the 
real environment. Changing the Med Rec process was complex and affected by many 
conditions. Unfortunately, the PL was seen by team members as the facilitator of the change 
and a powerful guiding coalition was not adequately formed. The lack of a powerful coalition set 
the change up to be resisted and not further continued after project completion. 
EBP Framework 
The Stetler Model of Evidence Based Practice was ideal in guiding the implementation of 
this EBP project. The Stetler EBP Model has five phases: (1) preparation, (2) validation, (3) 
comparative evaluation/decision making, (4) translation/application, and (5) evaluation (Dang et 
al., 2015 & Young, 2015). In the first phase, preparation, a problem is identified; the context of 
the problem is reviewed; and searching for evidence occurs. In the validation phase, the body of 
evidence is systematically searched. The second stage also includes choosing and 
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summarizing the evidence. The third phase involves organizing and condensing the evidence. 
The fourth phase involves the actual change in practice, or translation/application. The evidence 
is converted into the recommended intervention of change. The application is planned and the 
implementation strategy is put into action. Evaluation is the fifth, and final stage, of the Stetler 
Model. The evaluation stage involves evaluating the plan and determining if the goals were met 
(Dang et al., 2015 & Young, 2015). 
EBP Framework Appropriateness. The Stetler EBP Model was appropriate and 
extremely applicable to this EBP project. The model detailed the process of successfully 
implementing evidence into practice. The model re-enforced using literature in clinical practice 
to improve a clinical problem.   
 Strengths of EBP Framework. Strengths of the Stetler EBP Model included an easy to 
follow step-by-step approach to implementing evidence into practice. The step-by-step 
approach was extremely helpful to the novice PL. Although the patient population and setting 
was specific, the Stetler EBP Model was easily applied. The visual flowchart and graph that 
detailed the steps of EBP implementation were helpful. The steps laid the foundation for 
successful EBP implementation. The foundation and focus of the Stetler EBP Model is critical 
thinking and using research findings to guide care, which was the ultimate goal of this EBP 
project.  
Limitations of EBP Framework. The Stetler EBP Model’s limitations include the 
number of steps and also the complexity of each step. The steps at times seemed 
overwhelming and lengthy. Finally, the model flows in a linear pattern, and as discussed with 
the Kotter’s Model of Change, EBP implementation is complex. 
Implementation Modifications 
The implementation of the EBP project was fully supported by the site contact and the 
medical director of the clinic. One meeting was set up with the medical director to review the 
project, proposed data collection/outcomes, and the intervention. The medical director desired 
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to educate the other physicians on the project, data collection requirements, and intervention. 
Also, the timeframe was adjusted, the medical director was willing to collect data for three 
weeks pre-intervention and three weeks post-intervention, on every patient. 
 During Phase 1 data collection, team members became suspicious of the physician data 
collection and began asking the PL questions. It was imperative not to discuss the details of 
data being collected, in an effort to ensure behaviors did not change based on process 
monitoring. There is a chance that the team members discovered the Med Rec process was 
being tracked and sought to improve accuracy prior to the intervention.  
The PL developed a script used during correctness data collection to ensure consistent 
representation of the project and data collection. Also, during Phase 1 the PL had to inform the 
charge nurse of the project and data collection. This was in an effort to provide competent 
ethical care to the patients whose Med Rec needed clarification or additional follow up. 
 The team members were receptive during the education component of the intervention. 
Role responsibility in the Med Rec process was clearly defined and agreed upon at this time. 
Once the team member data collection began, the team members often discussed the 
additional time the data collection form required. The PL was available during Phase 2 to 
reassure and encourage team members of the importance of accurate Med Rec. There were no 
physician’s present during the unit meeting when the Med Rec education was provided by the 
PL. 
Future Modifications 
In the future if this project were to be re-implemented, there are modifications that may 
be beneficial. Prior to implementation of future Med Rec focused EBP projects a specific 
process to manage Med Rec inaccuracies found should be formulated. This would be in an 
effort to coordinate care and ensure patient safety.  
Calling all caregivers to review Med Rec correctness may be beneficial to increasing the 
participant number and allowing a clearer picture of physician versus PL data. Ideally, the PL 
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would be able to collect all the Med Rec accuracy data via the EHR and the physicians would 
not be involved in data collection. However, it is important to consider the time component of 
making the correctness telephone calls. The location of the telephone calls should also be taken 
into consideration. During the project, the location of the telephone calls was a computer and 
phone located in a busy hall, which was less than ideal when explaining the project to patients 
and verifying, oftentimes numerous, medications.  
Ideally, the physicians would have been educated by the PL regarding data collection 
and also would have been present during the team member education component. This may 
have increased buy-in to the project. The Med Rec process monitoring was considered time 
consuming by team members and is not present in the literature, one could consider not 
tracking this. Finally, the team members may have benefited from more individualized Med Rec 
accuracy updates. Individualized Med Rec accuracy reports may have increased the 
accountability for inaccurate Med Recs. 
Strengths and Limitations of the EBP Project 
Strengths 
 Strengths of this project include the use of Kotter’s Model of Change and Stetler’s EBP 
Model as a foundation. The use of these frameworks emphasized using existing evidence to 
implement and change practice in the clinical setting. The literature, although not specific to the 
population and setting, was the foundation for improving the Med Rec process in the pediatric 
hematology/oncology outpatient setting. The Stetler EBP Model guided the projects use of 
literature to improve a clinical problem. This was in combination with Kotter’s Model of Change 
that addressed barriers to change in the real life environment. 
 The EBP project was focused on a collaborative effort between team members, 
caregivers, and patients. This is important given the dynamic, complex medication regimens 
many of the pediatric hematology/oncology patients are using. Education included all team 
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members present at the unit meeting. The project addressed a topic and clinical problem that 
needed attention and improvement.  
Upon searching the current literature, common intervention and outcome themes were 
found. The intervention and outcomes used during this EBP project were consist with existing 
literature. Although the tools used in this project were self-developed by the PL, they were 
based on the common terms and components of accurate Med Recs found in the literature. By 
using common concepts found in the literature, it allowed the EBP project findings to be 
compared to existing literature and guided future modifications and improvement of the project.  
 Finally, the PL was familiar with the team members, caregivers, patients, and Med Rec 
process at the project site. This facilitated a trusting relationship in which improvement was 
possible. The PL was able to foresee barriers to improvement and successfully navigate the 
implementation of evidence into practice. 
Limitations 
 The specific patient population and setting target of this EBP project limited the 
applicable research found by the PL. However, current literature focused on pediatric inpatient 
and adult outpatient studies was used to develop an intervention aimed at improving the Med 
Rec process and ultimately patient safety. 
 The data collection, specifically calling the caregivers for correctness verification was 
time consuming, and presents a barrier to continuation of the Med Rec accuracy tracking 
process. No medication errors were reported during the EBP project timeframe or during the 
previous year. Therefore, this was may not have been an appropriate measure of the effect of 
inaccurate Med Recs on ADE’s. The EBP project took place in a specific setting, serving a 
specific population, this may limit the applicability of the project findings to other clinical settings. 
Implications for the Future 
 The EBP project can impact Med Rec accuracy in the outpatient setting, specifically the 
pediatric outpatient setting, in numerous ways. Areas that may be affected by the project 
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findings include practice, theory, research, and education. Overall, the project adds to the body 
of evidence focused on Med Rec process accuracy and patient safety. 
Practice 
 The implementation of the standardized, collaborative Med Rec process during the EBP 
project did result in a significant increase in the matched physician reported accurate Med Recs. 
And although not significant, there was an increase in the total physician reported accurate Med 
Recs. This indicates that continuation of the patient/caregiver and team member component of 
the intervention may be helpful in further improvement of the Med Rec process. In order to 
continue tracking of the Med Rec process, specifically the accuracy, tracking measures must be 
re-examined and a less time consuming option may be appropriate. It must be determined if 
particular parts of the intervention, such as the caregiver reminder to bring their child’s 
medications, should continue. Also, continued tracking of the Med Rec process compliance may 
not be necessary. The physicians may need to be included in the education and inaccuracy 
data updates, as they were not recording numerous incompleteness errors that the PL found.  
 All team members and caregivers/patients are critical to the success of an accurate Med 
Rec process. Without everyone invested in the process improvement, future implemented 
measures may meet the same resistance. The MA and nurse are the bridge between the patient 
and provider. They are responsible for educating the caregivers/patients regarding their 
medications and interacting with the caregiver/patient to produce the most accurate Med Rec. 
 The pediatric hematology/oncology outpatient clinic may benefit from further discussion 
and refinement of the evidence-based intervention. Also, discussions with the IT department 
may be beneficial in setting up a process in which the EHR would stop forward movement, a 
hard stop, in the Med Rec process unless each medication had a name, dose, frequency, and 
route of administration documented. This would eliminate the incompleteness factor of the 
inaccurate Med Recs.  
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Theory 
 There is a large amount of literature detailing the role of Med Rec in improving patient 
safety. However, there is also discussion in the literature surrounding the difficulties with 
implementing an accurate Med Rec process. A barrier discussed in detail in the literature is the 
different processes that exist in various settings and with various populations. Using theoretical 
and EBP frameworks when implementing evidence into practice in the future will ensure 
development and forward movement of refining the Med Rec process. Using the Kotter’s Model 
of Change and Stetler’s EBP Model as frameworks for this EBP project facilitated the use of the 
best evidence into clinical practice. Future use of the Stetler EBP Model to implement and 
improve Med Rec processes is recommended. 
Research 
 In the future, the EBP project could be modified and replicated in the same setting to 
strive for further improvement of Med Rec accuracy. The project could also be replicated to 
determine if a significant increase in Med Rec accuracy can be achieved in a similar or different 
outpatient setting. Implementing similar interventions and outcomes would be helpful in 
comparing future findings. There is a lack of literature focused on the Med Rec process in the 
pediatric outpatient setting, more research focusing on this specific patient population and 
setting would fill this gap.  
Education 
 The education provided to team members during the intervention, regarding the 
completeness, correctness, and accuracy of the Med Rec process could be provided to all 
healthcare providers and team members regardless of the setting. Moving forward improving 
patient safety will continue to be a much discussed topic. Med Rec should be promoted as a 
means to improve patient safety. Whether it be in the educational or clinical setting, increasing 
knowledge of the importance of an accurate Med Rec process must be a focus. The EHR and 
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complexity of medical care today has increased the need for patient and provider collaboration, 
in an effort to improve medication safety. 
Conclusion 
 The standardized and collaborative Med Rec process increased the number of physician 
reported accurate Med Recs. The physicians reported mostly incorrectness errors, while the PL 
reported mostly incompleteness errors. The most commonly assigned Med Rec inaccuracy 
severity was class 1 (minor). There were no voluntary reported medication errors during the 
duration of the EBP project. In general, the project was well received and shed light on a 
process that can lead to improved patient safety. The complexity of oncology care, coupled with 
the complexity of pediatric medication administration, places pediatric oncology patients at a 
significant risk for medication discrepancies and subsequent adverse drug events (Walsh et al., 
2009). Furthermore, a standardized, collaborative Med Rec process can be used to improve 
patient safety in this vulnerable population.  
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Appendix A 
Pre-Intervention Medication Reconciliation Process Team Member Survey 
Pediatric Hematology/Oncology Outpatient Clinic 
Medication Reconciliation (Med Rec) Process Team Member Survey Pre-Intervention 
Instructions:  
Please complete the following items by filling in the blank or marking the item that best 
describes you. 
Date: Last three digits of employee number: 
Age: Gender:               Female               Male 
Ethnicity:           African American                   Asian-Pacific Islander             Caucasian 
                          Hispanic                                Native American                     Other _________ 
Highest Level of Education:          Less than high school               High school/ GED                   
                            Some college              2 year college degree (Associates)            
                            4 year college degree (Bachelors)              Master’s Degree                                           
                            Doctoral Degree                 Professional Degree (MD, JD) 
Current Employment Status:          Full-time                   Part-time                  PRN 
Current Position:       Physician        Nurse         Medical Assistant        Unit Assistant 
How long have you worked in this outpatient clinic?  
What aspects of the current Med Rec process do you feel are working well? 
 
 
What aspects of the current Med Rec process do you feel are NOT working well? 
 
 
Please provide ideas for future improvement of the Med Rec process. 
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Appendix B 
Post-Intervention Medication Reconciliation Process Team Member Survey 
Pediatric Hematology/Oncology Outpatient Clinic 
Medication Reconciliation (Med Rec) Process Team Member Survey Post-Intervention 
Instructions:  
Please complete the following items by filling in the blank or marking the item that best describes you. 
Thank you! 
Date: Last three digits of employee number: 
Age: Gender:               Female               Male 
Ethnicity:           African American                   Asian-Pacific Islander             Caucasian 
                          Hispanic                                Native American                     Other _________ 
Highest Level of Education:          Less than high school               High school/ GED                   
                            Some college              2 year college degree (Associates)            
                            4 year college degree (Bachelors)              Master’s Degree                                           
                            Doctoral Degree                 Professional Degree (MD, JD) 
Current Employment Status:          Full-time                   Part-time                  PRN 
Current Position:       Physician        Nurse         Medical Assistant        Unit Assistant 
How long have you worked in this outpatient clinic?  
Should the patients/parents continue to be reminded to bring their medications to their next visit?  
          Yes              No 
If not, what is the reason? 
If so, do you have any suggestions to improve the reminder? 
Should the patient/parent education regarding Med Rec continue?              Yes              No 
If not, what is the reason? 
If so, do you have any suggestions to improve the education? 
Should tracking of the Med Rec process and discrepancies continue?          Yes              No 
If not, what is the reason? 
If so, do you have any suggestions to improve the monitoring? 
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Appendix C 
Physician Medication Reconciliation Tracking Form 
Patient Initials: _______    Patient DOB: ________ 
Patient Code Number: __________ 
 
Physician Medication Reconciliation Tracking Form 
Medication List Information 
 Yes No 
(if no continue to table below) 
Medication list accurate 
(Accurate= complete and correct Med Rec) 
 
 
 
 
 
 What makes the Med Rec inaccurate? 
(Please provide more information in tables 
below.) 
A. Incompleteness 
(Complete= name, dose, frequency, and route of all 
meds documented) 
 
B. Incorrectness 
(Correct= no discrepancies between the med list in 
EHR and the meds the patient is taking at home) 
 
 
Medication Discrepancy Data 
A. Completeness 
 Place check next to what med 
element is missing. 
Name of med(s) missing this information? 
Name   
Dose   
Frequency   
Route   
 
B. Correctness 
 Place check next to what 
element is incorrect. 
Name of med(s) with the 
incorrect information? 
Addition 
(med on Med Rec that patient is not taking) 
  
Omission  
(med not on Med Rec that patient is taking) 
  
Duplication  
(med listed twice) 
  
Incorrect name  
(med with incorrect name) 
  
Incorrect dose  
(med with incorrect dose) 
  
Incorrect frequency  
(med with incorrect frequency) 
  
Incorrect route  
(med with incorrect route) 
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Severity of Discrepancies 
 Place a check next to the severity of the Med Rec 
discrepancy. 
Class 1  
(potentially minor) 
 
Class 2 
(potentially moderate) 
 
Class 3 
(potentially severe) 
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Appendix D 
Project Leader Medication Reconciliation Tracking Form 
Project Leader Medication Reconciliation Tracking Form 
Patient Code Number: ______ 
Patient Demographic Data 
Age (years) 
 
 
Gender 
 
              Female               Male 
Diagnosis 
 
 
Number of medications the patient is taking 
(includes OTC, herbal supplements, vitamins, and 
prescriptions) 
 
Was the Med Rec correctness verified via telephone? 
 
             Yes              No 
Who verified Med Rec correctness via telephone? 
 
 
 
Medication List Information 
 Yes No 
(if no continue to table below) 
Medication list accurate 
(Accurate= complete and correct Med Rec) 
 
 
 
 
 
 What makes the Med Rec inaccurate? 
A. Incompleteness 
(Complete= name, dose, frequency, and route of all  medications 
documented) 
 
B. Incorrectness 
(Correct= no discrepancies between the medication list in EHR and 
the medications the patient is taking at home) 
 
 
Medication Discrepancy Data 
A. Completeness 
 Place check next to what med 
element is missing. 
Name of med(s) missing this information? 
Name   
Dose   
Frequency   
Route   
 
B. Correctness 
 Place check next to what 
element is incorrect. 
Name of med(s) with this incorrect 
information? 
Addition 
(med on Med Rec that patient is not taking) 
  
Omission  
(med not on Med Rec that patient is taking) 
  
Duplication  
(med listed twice) 
  
Incorrect name  
(med with incorrect name) 
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Incorrect dose  
(med with incorrect dose) 
  
Incorrect frequency  
(med with incorrect frequency) 
  
Incorrect route  
(med with incorrect route) 
  
 
Severity of Discrepancies 
 Place a check next to the severity of the Med Rec 
discrepancy. 
Class 1 (potentially minor)  
Class 2 (potentially moderate)  
Class 3 (potentially severe) 
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Appendix E 
Educational Patient Handout 
Medication Reconciliation 
Medication reconciliation ensures the most up-to-date list of your medications is 
available.  
 
This up-to-date list benefits both you and the healthcare team. 
 
Medication reconciliation promotes medication safety. 
 
Medication reconciliation is the responsibility of the patient and the healthcare 
team.  
 
Successful medication reconciliation is a collaborative effort. 
 
Medications include:  
 prescription medications 
 over-the-counter medications 
 vitamins 
 nutritional supplements 
 complementary medications 
 
Your role in medication reconciliation: 
 Bring your child’s medications to every visit. 
 Question you should be able to answer include: 
o What medications does your child take, including the name, dose, frequency, 
and route? 
o Why are they taking them? 
o How do they take them? 
o When was the last time they took each medication? 
o Are they having any problems with their current medications? 
 
Together, with you, we want to improve your child’s medication safety. 
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Appendix F 
Educational Power Point ® 
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Appendix G 
Medication Reconciliation Team Member Information Sheet 
MEDICATION RECONCILIATION  
3 steps: 
Verification 
Clarification 
Reconciliation 
 
Complete 
Name, dose, frequency, and route of all meds are documented 
Correct  
No discrepancies between the med list in the EHR and 
 the meds the patient is taking at home exist 
Accurate 
Complete and Correct Med Rec 
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Appendix H 
Master Coding Form 
Master Coding Form 
Code 
Number 
Patient Name Medical Record Number 
(MRN) 
DOB 
1 
 
   
2 
 
   
3 
 
   
4 
 
   
5 
 
   
6 
 
   
7 
 
   
8 
 
   
9 
 
   
10 
 
   
11 
 
   
12 
 
   
13 
 
   
14 
 
   
15 
 
   
16 
 
   
17 
 
   
18 
 
   
19 
 
   
20 
 
   
21 
 
   
MEDICATION RECONCILIATION  114  
 
Appendix I 
Medication Reconciliation Process Data Collection Form 
 
 
 
Patient Code Number: __________ 
Medication Reconciliation Process Data Collection Form 
Instructions: Please complete the following items for each patient and place the completed form 
in the locked box. Thank you. 
 
Task 
 
Yes No 
Was the caregiver reminded to 
bring the patient’s medications 
to the next visit? 
 
 
 
 
 
 
Did the patient/caregiver bring 
their medications to the 
appointment? 
 
  
Was the patient/caregiver given 
the brochure and educated 
regarding medication 
reconciliation, during their visit? 
By Who (role)? 
 
MA 
 
  
Nurse  
Both  
Were all three steps of the 
medication reconciliation 
process completed?  
By Who (role)? 
 
(Verification= generating a list of 
the patient’s current medications) 
(Clarification= medications are 
checked for appropriateness) 
(Reconciliation= medication list is 
reviewed and any changes are 
documented) 
 
Verification MA   
Nurse  
Both  
Clarification MA   
Nurse  
Both  
Reconciliation Physician   
 
 
 
Patient Label 
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Appendix J 
Ethics Training Completion Certificate 
 
